13_cis_retinoic_acid
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   10.6160    5.4820   -0.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9350    3.3080   -0.3420 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1650   -3.7930   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9360   -5.2870   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -6.0950   -0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4270   -3.2930    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2930   -5.6270    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720   -4.1470    0.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180   -3.1060    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2620   -3.5100   -1.8950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   -1.8530    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5940   -3.7230    1.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5660   -1.0700    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5800    0.3580    0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3000    1.0310    0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7270    1.0260    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8760    2.4440    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0420    3.0690    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2550    4.4870    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0830    5.3300    0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4270    5.0940    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7040    4.4870   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  8 12  1  0  0  0  0
 11 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
13_cis_retinoic_acid

> <PRIMARY_SOM>
7

>  <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

$$$$
1_2-dibromoethane
  MOE2008           3D

  4  3  0  0  0  0  0  0  0  0999 V2000
   -0.4080   -0.0260    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -0.1780    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -0.3030    1.8020 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020   -1.8040    0.3000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
M  END
>  <ID>
1_2-dibromoethane

> <PRIMARY_SOM>
1 2 3 4

>  <Citation>
Wormhoudt et al., Chemico-Biological Interactions, 1996, 101,175-192

>  <DOI>
10.1016/0009-2797(96)03723-4

$$$$
2_2_4_4_5_5-hexachlorobiphenyl
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -1.4270   -0.6110   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -0.3470    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440   -0.3330    1.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6140   -0.5800    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3910   -0.8450    0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7980   -0.8600   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6990   -1.1790   -2.3100 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.0760   -1.1440    0.6300 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -0.0100    2.8340 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8120   -0.0990   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2580    1.2150   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    1.4960   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5550    0.4610   -0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1310   -0.8490   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7720   -1.1270   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3190   -2.7740    0.2730 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.2490    0.7350   -0.6060 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.0710    3.1400   -0.7440 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 12 18  1  0  0  0  0
 13 14  2  0  0  0  0
 13 17  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
2_2_4_4_5_5-hexachlorobiphenyl

> <PRIMARY_SOM>
4 14

>  <Citation>
Ariyoshi et al., Biochem. Biophys. Res. Commun., 1995, 212, 455-460

$$$$
2-acetylbenzothiophene
  MOE2008           3D

 12 13  0  0  0  0  0  0  0  0999 V2000
    1.3680   -0.0260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -1.0630    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8970   -0.6570    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9960    0.7350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5590    1.4760    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -1.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3260   -0.7760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980    0.6090   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410    1.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -0.1330    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4080   -1.2100    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6040    1.1440    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  5  1  0  0  0  0
  1 10  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
M  END
>  <ID>
2-acetylbenzothiophene

> <PRIMARY_SOM>
5

>  <Citation>
Elizabeth M. Joshi, Brian H. Heasley, Mahendra D. Chordia, and Timothy L. Macdonald, In Vitro Metabolism of 2-Acetylbenzothiophene:  Relevance to Zileuton Hepatotoxicity, Chem. Res. Toxicol., 2004, 17 (2), pp 137~143

>  <DOI>
10.1021/tx0341409

$$$$
2-oxo-clopidogrel
  MOE2008           3D

 22 24  0  0  1  0  0  0  0  0999 V2000
    2.3410    0.8880   -2.5910 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.0480   -0.1610   -0.2760 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6660   -2.1660    1.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8490   -2.7790   -0.9110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5530   -0.5770    0.0300 N   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2650   -1.7260   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1350    0.6520   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8620   -0.6400   -0.3760 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.7230   -1.7600   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6250    0.6790   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3490   -0.4230   -0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050    0.5370    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3790    1.9510   -0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5150   -1.9750   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8270    1.5470   -0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7510    2.4310   -0.7350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4170    1.2760   -0.9150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000    0.9140    1.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2020    2.3620   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5840    1.9980    1.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2860    2.7220    0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2970   -3.4120    1.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0  0  0  0
  2 11  1  0  0  0  0
  2 15  1  0  0  0  0
  3 14  1  0  0  0  0
  3 22  1  0  0  0  0
  4 14  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  5  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 12  1  0  0  0  0
  8 14  1  0  0  0  0
  9 11  1  0  0  0  0
 10 11  2  0  0  0  0
 10 13  1  0  0  0  0
 12 17  2  0  0  0  0
 12 18  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  2  0  0  0  0
 17 19  1  0  0  0  0
 18 20  2  0  0  0  0
 19 21  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
2-oxo-clopidogrel

> <PRIMARY_SOM>
2

>  <Citation>
Kazui et al., Drug Metab. Dispos.,2010, 38, 92-99

>  <DOI>
10.1124/dmd.109.029132

$$$$
3-O-methylfluorescein
  MOE2008           3D

 26 30  0  0  1  0  0  0  0  0999 V2000
    0.5560   -0.9440    1.7110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4780    2.2140   -0.6820 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2590   -2.9630    2.5790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0450    1.2880   -0.3330 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8650    4.0800   -0.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3640   -0.3470    0.3960 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7420   -1.4670   -0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.0500    0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980    0.8400    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1180   -2.5640    0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4170    1.2920   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8220    2.0350   -0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0040   -2.2330    1.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7640   -1.5300   -1.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1400   -0.8080    0.6370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500    0.7700    0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5310   -3.7550   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7520    1.6620   -0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6700    3.1310   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4760   -0.4340    0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750   -2.7220   -2.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4970    1.8650    0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7870    0.8040   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5570   -3.8280   -1.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0020    3.0350   -0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1330    0.4510    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  1  0  0  0  0
  1 13  1  0  0  0  0
  2 11  1  0  0  0  0
  2 12  1  0  0  0  0
  3 13  2  0  0  0  0
  4 23  1  0  0  0  0
  4 26  1  0  0  0  0
  5 25  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7 10  2  0  0  0  0
  7 14  1  0  0  0  0
  8 11  2  0  0  0  0
  8 15  1  0  0  0  0
  9 12  2  0  0  0  0
  9 16  1  0  0  0  0
 10 13  1  0  0  0  0
 10 17  1  0  0  0  0
 11 18  1  0  0  0  0
 12 19  1  0  0  0  0
 14 21  2  0  0  0  0
 15 20  2  0  0  0  0
 16 22  2  0  0  0  0
 17 24  2  0  0  0  0
 18 23  2  0  0  0  0
 19 25  2  0  0  0  0
 20 23  1  0  0  0  0
 21 24  1  0  0  0  0
 22 25  1  0  0  0  0
M  END
>  <ID>
3-O-methylfluorescein

> <PRIMARY_SOM>
26

>  <Citation>
Sudsakorn et al., Drug Metab. Dispos., 2007, 35, 841-847

>  <DOI>
10.1124/dmd.106.014472

$$$$
3-cyano-7-ethoxycoumarin
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5570    1.5720   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 15  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 15 16  3  0  0  0  0
M  END
>  <ID>
3-cyano-7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ekins et al.,J. Pharmacol. Exp. Ther.,286,1253,1998

$$$$
3-cyano-7-methoxycoumarin
  MOE2008           3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 14 15  3  0  0  0  0
M  END
>  <ID>
3-cyano-7-methoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Stresser et al.,Drug Metab. Disp.,30,845,2002

>  <DOI>
10.1124/dmd.30.7.845

$$$$
3-ethoxy-4-trifluoromethylcoumarin
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4650   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5450    1.5830   -0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0890   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4170    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4690   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 18  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
3-ethoxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
E. L. Code, C. L. Crespi, B. W. Penman, F. J. Gonzalez, T. K. H. Chang, D. J. Waxman, Drug Metab. Dispos. 1997, 25, 985-993.

$$$$
3-methoxy-4-trifluoromethylcoumarin
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 17  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 17  1  0  0  0  0
M  END
>  <ID>
3-methoxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ghosal et al.,Biopharm. Drug Disp.,24,375,2003

>  <DOI>
10.1002/bdd.374

$$$$
4-chloromethyl-7-ethoxycoumarin
  MOE2008           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3010    0.6480    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1110    1.3590   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.6630   -0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220    1.4250   -0.2790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3910    0.6150   -0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840    1.5260   -0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910   -0.7310   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1100   -1.4280    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3230   -0.7430    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6060   -1.4210    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6680   -2.9040    0.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5540   -3.6600   -1.2370 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7160   -0.6880    0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7200    0.7750    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7670    1.4060    0.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4900    1.3980    0.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 16  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 13  2  0  0  0  0
 11 12  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <ID>
4-chloromethyl-7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Ekins et al.,J. Pharmacol. Exp. Ther.,286,1253,1998

$$$$
4-vinylcyclohexene
  MOE2008           3D

  8  8  0  0  1  0  0  0  0  0999 V2000
    1.1900    0.6800    0.1770 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.3970    1.2320    0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400    2.2210    1.7380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1060    1.3910    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3270    0.6470    0.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3030   -0.6240   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630   -1.4470   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1090   -0.8150    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  8  1  0  0  0  0
  2  3  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
4-vinylcyclohexene

> <PRIMARY_SOM>
2 3

> <SECONDARY_SOM>
5 6

>  <Citation>
Fontaine et al.,Drug Metab. Disp.,29,179,2001

$$$$
5_hydroxytryptamine
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5260    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950    2.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3760   -0.5120    0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2370    2.2590   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1200    2.4120    1.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4630    2.7530   -0.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0480    2.0730   -2.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3590    2.8340    0.6720 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4800    3.0530   -1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0700    2.3760   -3.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2830    2.8650   -2.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8910    2.1970   -4.7650 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  2  0  0  0  0
  5  7  2  0  0  0  0
  5  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  2  0  0  0  0
 10 12  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
5_hydroxytryptamine

> <PRIMARY_SOM>
2

>  <Citation>
Fradette et al.,Br. J. Pharmacol.,141,407,2004

>  <DOI>
10.1038/sj.bjp.0705632

$$$$
5betacholestane-3_7_12_trihydroxy
  MOE2008           3D

 78 81  0  0  1  0  0  0  0  0999 V2000
    0.5710    0.8100    1.5670 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9170    0.7130   -2.4810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8840    3.6380    0.1980 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6840   -1.3280    0.3480 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.0720   -0.8120   -0.8980 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5890   -1.0390   -0.8210 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.1490   -0.2990    0.4400 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.7090   -0.4910    0.5850 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1350   -1.0170   -0.1050 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.1820   -0.5630    1.5890 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.3520   -0.6550    1.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4130   -0.0090   -0.7270 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6970   -1.4270   -2.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3110   -0.6050   -2.1120 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1600   -1.4530   -1.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8350   -0.6850   -1.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3020    0.2990    1.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5000   -2.8510    0.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2510   -1.6460    0.7170 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.4220    1.5280   -0.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0700   -1.9800    0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2670    1.8120    1.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0030    2.2270    0.3500 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.6560   -1.2640    0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180   -1.2320    2.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9650    0.2380    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3460    0.5550   -0.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6840    2.0590   -0.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6170    2.6700    0.9720 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7280    2.8080   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0950    0.2740   -0.9640 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7720   -2.1130   -0.7120 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9650    0.7720    0.2920 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.2540    0.0740   -0.0920 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880   -0.9800    2.5120 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6570    0.0230    2.5350 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6110   -1.6680    2.0560 H   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4700   -0.3090   -0.6710 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.5920   -0.8350   -2.9820 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.3490   -2.4420   -2.2890 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0040   -1.2570   -2.9380 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.5710   -2.4610   -1.7170 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.7760   -0.7690   -2.1810 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1290   -1.7420   -1.9850 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2970   -0.2390   -2.8760 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8050    0.0260    2.7250 H   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3530    0.0060    1.9250 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.0150   -3.1750    1.5060 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5480   -3.1320    0.7250 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.8890   -3.4600   -0.2250 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930   -2.7400    0.6670 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4250    1.9370   -1.0490 H   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0070    1.8140   -1.7580 H   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1580   -2.1170    0.8560 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6810   -2.6540    0.0740 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940   -2.3260    1.8080 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7330    2.2920    2.4860 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2350    2.1810    1.6000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0700    1.9900    0.4360 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.2480    1.2240    2.3850 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.4100   -1.7540    0.8380 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.7960   -1.6870   -0.7950 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6620    1.2180   -1.6950 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.8890   -0.1700    2.3120 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.0600   -1.4140    2.7200 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.3840   -1.8430    2.7160 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.2110    0.7370   -0.4650 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.8840    0.6440    1.1610 H   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2780    4.0530    0.9850 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.4090    0.1680   -1.4600 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.1080    0.0230    0.1470 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.7050    2.1750   -0.8110 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.5930    2.7310    1.3540 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.0170    3.6900    0.9580 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.2170    2.0880    1.6800 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.7040    2.8400   -0.9750 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.0590    3.8460   -1.4830 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.7090    2.3510   -2.3560 H   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0  0  0  0
  1 60  1  0  0  0  0
  2 14  1  0  0  0  0
  2 63  1  0  0  0  0
  3 23  1  0  0  0  0
  3 69  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 18  1  0  0  0  0
  5  6  1  0  0  0  0
  5 13  1  0  0  0  0
  5 31  1  0  0  0  0
  6  7  1  0  0  0  0
  6 14  1  0  0  0  0
  6 32  1  0  0  0  0
  7  8  1  0  0  0  0
  7 11  1  0  0  0  0
  7 33  1  0  0  0  0
  8 12  1  0  0  0  0
  8 17  1  0  0  0  0
  8 21  1  0  0  0  0
  9 15  1  0  0  0  0
  9 19  1  0  0  0  0
  9 34  1  0  0  0  0
 10 11  1  0  0  0  0
 10 35  1  0  0  0  0
 11 36  1  0  0  0  0
 11 37  1  0  0  0  0
 12 16  1  0  0  0  0
 12 20  1  0  0  0  0
 12 38  1  0  0  0  0
 13 15  1  0  0  0  0
 13 39  1  0  0  0  0
 13 40  1  0  0  0  0
 14 16  1  0  0  0  0
 14 41  1  0  0  0  0
 15 42  1  0  0  0  0
 15 43  1  0  0  0  0
 16 44  1  0  0  0  0
 16 45  1  0  0  0  0
 17 22  1  0  0  0  0
 17 46  1  0  0  0  0
 17 47  1  0  0  0  0
 18 48  1  0  0  0  0
 18 49  1  0  0  0  0
 18 50  1  0  0  0  0
 19 24  1  0  0  0  0
 19 25  1  0  0  0  0
 19 51  1  0  0  0  0
 20 23  1  0  0  0  0
 20 52  1  0  0  0  0
 20 53  1  0  0  0  0
 21 54  1  0  0  0  0
 21 55  1  0  0  0  0
 21 56  1  0  0  0  0
 22 23  1  0  0  0  0
 22 57  1  0  0  0  0
 22 58  1  0  0  0  0
 23 59  1  0  0  0  0
 24 26  1  0  0  0  0
 24 61  1  0  0  0  0
 24 62  1  0  0  0  0
 25 64  1  0  0  0  0
 25 65  1  0  0  0  0
 25 66  1  0  0  0  0
 26 27  1  0  0  0  0
 26 67  1  0  0  0  0
 26 68  1  0  0  0  0
 27 28  1  0  0  0  0
 27 70  1  0  0  0  0
 27 71  1  0  0  0  0
 28 29  1  0  0  0  0
 28 30  1  0  0  0  0
 28 72  1  0  0  0  0
 29 73  1  0  0  0  0
 29 74  1  0  0  0  0
 29 75  1  0  0  0  0
 30 76  1  0  0  0  0
 30 77  1  0  0  0  0
 30 78  1  0  0  0  0
M  END
>  <ID>
5betacholestane-3_7_12_trihydroxy

> <PRIMARY_SOM>
28

>  <Citation>
Furster and Wikvall, Biochim. Biophys. Acta, 1999, 1437, 46-52

>  <DOI>
10.1016/S0005-2760(98)00175-1

$$$$
6-aminochrysene
  MOE2008           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
    3.9590   -0.3410    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9710   -1.7600    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7300    0.3610   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1470    0.4000    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7200    1.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7470   -2.4650   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1580   -2.5120    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400    2.4970    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1550    1.7960    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4000    2.4610    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5400   -0.3830   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5430   -1.7730   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7310   -3.8600   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380   -3.9060    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5190    2.5120   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9080    3.9000    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9220   -4.5790   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5060    3.9040   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7050    4.6010    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  5  1  0  0  0  0
  3 11  2  0  0  0  0
  4  9  2  0  0  0  0
  5  8  2  0  0  0  0
  5 15  1  0  0  0  0
  6 12  2  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8  9  1  0  0  0  0
  8 16  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
6-aminochrysene

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
13 17

>  <Citation>
Yamazaki et al.,Carcinogenesis,14,1271,1993
Koehl et al.,Cancer Res.,56,316,1996

$$$$
7-benzyloxy-4-trifluoromethylcoumarin
  MOE2008           3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5440    1.5820   -0.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7980    0.7630   -1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9750    1.6820   -1.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 11  2  0  0  0  0
  1 20  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 13 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
7-benzyloxy-4-trifluoromethylcoumarin

> <PRIMARY_SOM>
5

>  <Citation>
Donato et al.,Drug Metab. Disp.32,699,2004

>  <DOI>
10.1124/dmd.32.7.699

$$$$
7-benzyloxyresorufin
  MOE2008           3D

 23 26  0  0  0  0  0  0  0  0999 V2000
    5.1790    1.2130    0.5290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8540    1.3000    0.0400 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4990    1.0090    0.9630 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -1.3890   -0.6930 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040    0.5560    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2400   -0.7100   -0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680    0.5580    0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9540   -0.7820   -0.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5240    1.2060    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7010    0.5940   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4250   -1.3130   -0.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6480   -0.6670   -0.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8360    1.1300    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6450   -1.4340   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5350    0.4730    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210   -0.8530   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9940    0.5850   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2160    1.4010   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9130    1.2670    1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0550    2.0300    1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5020    2.9270    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8080    3.0620   -0.9150 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6660    2.3000   -1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 23  2  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
7-benzyloxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Niwa et al.,Xenobiotica,33,717,2003

>  <DOI>
10.1080/0049825031000121617

$$$$
7-ethoxycoumarin
  MOE2008           3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    1.3350    0.6350    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1530    1.3550   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500    0.6620   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730    1.4310   -0.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3420    0.6270   -0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5300    1.5460   -0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -0.7360   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -1.4460   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410   -0.7550    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980   -1.4580    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7280   -0.7630    0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550    0.7030    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8120    1.3130    0.4350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    1.3580    0.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
7-ethoxycoumarin

> <PRIMARY_SOM>
5

>  <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

$$$$
7-pentoxyresorufin
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    5.2650    1.2870   -0.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9660    1.2130   -0.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5630    1.2360   -0.2660 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1490   -1.5190    0.3120 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4070    0.5370   -0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3620   -0.8290    0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0580    0.6230   -0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0640   -0.8250    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6240    1.1950   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8180    0.4910   -0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5620   -1.5240    0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7830   -0.8690    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9110    1.2820   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7570   -1.4820    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6110    0.6200   -0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170   -0.8130    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1220    0.4000   -0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3390    1.2660   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5860    0.4360   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8040    1.3010   -0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0500    0.4700   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1  7  1  0  0  0  0
  2 10  1  0  0  0  0
  2 17  1  0  0  0  0
  3 15  2  0  0  0  0
  4  6  1  0  0  0  0
  4  8  2  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  7 13  2  0  0  0  0
  8 14  1  0  0  0  0
  9 10  2  0  0  0  0
 10 12  1  0  0  0  0
 11 12  2  0  0  0  0
 13 15  1  0  0  0  0
 14 16  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
7-pentoxyresorufin

> <PRIMARY_SOM>
17

>  <Citation>
Hanna et al., Arch. Biochem. Biophys., 2000, 376, 206-216

>  <DOI>
10.1006/abbi.2000.1708

$$$$
8-OH-efavirenz
  MOE2008           3D

 22 24  0  0  1  0  0  0  0  0999 V2000
   -1.8520   -4.1700   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6250   -0.2560   -2.3270 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    1.3560   -2.2090 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    1.7930   -1.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.9860    0.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180    3.6190    1.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210    1.5290    1.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.7470    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -0.3270    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5280   -1.7350    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    0.6660   -0.2070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5030   -0.2520    0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9490   -0.2940    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630    0.1600    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    0.1810    0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160    0.8970   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.6530   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030   -0.6710    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3500   -0.1790    1.4860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1970    2.4430    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570   -2.5080   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1180   -2.0170    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  1  0  0  0  0
  2 16  1  0  0  0  0
  3 16  1  0  0  0  0
  4 16  1  0  0  0  0
  5 11  1  0  0  0  0
  5 20  1  0  0  0  0
  6 20  2  0  0  0  0
  7 15  1  0  0  0  0
  7 20  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 11 16  1  0  0  0  0
 12 14  3  0  0  0  0
 13 15  2  0  0  0  0
 13 17  1  0  0  0  0
 15 18  1  0  0  0  0
 17 21  2  0  0  0  0
 18 19  1  0  0  0  0
 18 22  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
8-OH-efavirenz

> <PRIMARY_SOM>
8

>  <Citation>
Ward et al., J. Pharm. Exp. Ther., 2003, 306, 287-300

>  <DOI>
10.1124/jpet.103.049601

$$$$
9_anthraldehyde
  MOE2008           3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4600   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770    2.1810    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2650    2.1200    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.6950   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180   -0.6990   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    1.5080   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4100    1.3890    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4390    0.0450   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -0.0040   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6200    2.2180    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6860   -0.6010   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7940    1.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8280    0.1400   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630   -2.1100   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2290   -2.7390    0.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 15  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  2  0  0  0  0
M  END
>  <ID>
9_anthraldehyde

> <PRIMARY_SOM>
15

>  <Citation>
Watanabe et al.,Drug Metab. Pharmacokin.,17,516,2002

$$$$
9_cis_retinoic_acid
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.2530    1.5870    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2450    0.1890    0.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8320    2.3700   -0.4360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3920    2.0930    1.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4160   -0.4760    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3600   -2.4500   -0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5600   -1.7300   -0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8010   -1.8330   -0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1720   -1.7850   -0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4150   -1.8740   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9780   -2.5010   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5910   -2.5420   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5350   -0.5150   -1.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7370   -2.3880   -1.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9040    3.8640   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6640    3.5940    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4540    1.7260   -1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5400    1.8360    2.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7120    1.3540    1.9430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6190    4.2870    1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1410   -0.2820   -0.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1150   -2.6360   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  3 15  1  0  0  0  0
  3 17  1  0  0  0  0
  4 16  1  0  0  0  0
  4 18  1  0  0  0  0
  4 19  1  0  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  6  9  2  0  0  0  0
  7 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 11  1  0  0  0  0
  9 21  1  0  0  0  0
 10 12  2  0  0  0  0
 10 22  1  0  0  0  0
 15 20  1  0  0  0  0
 16 20  1  0  0  0  0
M  END
>  <ID>
9_cis_retinoic_acid

> <PRIMARY_SOM>
15

>  <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

$$$$
AMMC
  MOE2008           3D

 22 23  0  0  0  0  0  0  0  0999 V2000
    1.2550    0.6470   -0.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710    1.3510   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1430    0.7520   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2610    1.5030   -0.4840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4440    0.7980   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550   -0.5400    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -1.2310    0.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630   -0.6410    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5380   -1.3210    0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5100   -2.7090    0.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6750   -0.6910    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0160   -1.3320    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8780   -0.5930    1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2660   -1.1700    1.2510 N   0  3  0  0  0  0  0  0  0  0  0  0
    7.9520   -1.2620   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9940    0.1000   -0.7490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2950   -2.4960    1.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7040   -3.5890    1.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0600   -0.2420    2.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    0.6770   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370    1.2400   -0.7950 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.2960   -0.7200 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 22  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 20  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 14 19  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 20 21  2  0  0  0  0
 20 22  1  0  0  0  0
M  CHG  1  14   1
M  END
>  <ID>
AMMC

> <PRIMARY_SOM>
5

>  <Citation>
Chauret et al.,Drug Metab. Disp.,29,1196,2001

$$$$
BFC
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.1100    1.2610   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0110   -0.1270   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    2.0910   -0.0250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3510    1.8940    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3440   -0.7250   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580   -0.8880    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3040    1.5500   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5080    1.1200    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.0910   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090   -0.2710    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3110    2.2480   -0.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040   -2.2080   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8080   -2.5900   -0.0520 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9560   -2.7790    1.0730 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9170   -2.7810   -1.1100 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6900    1.8070    0.0580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8030    0.9170    0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0630    1.7130    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6730    2.0820   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8500    2.8260   -1.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4190    3.2030    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8120    2.8360    1.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6350    2.0910    1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 12  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  2  0  0  0  0
  8 10  1  0  0  0  0
  8 16  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 23  2  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
BFC

> <PRIMARY_SOM>
17

>  <Citation>
Renwick et al.,Xenobiotica,30,955,2000

$$$$
CP_125_611
  MOE2008           3D

 26 28  0  0  1  0  0  0  0  0999 V2000
    0.8370    0.6700   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4420    1.2230   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2500    1.1140   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6340    1.6900   -0.0550 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7660    0.4380    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5120   -0.1160    1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3130    0.0020   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7090    3.2000   -0.3090 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.0000    4.0160    0.6700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6120    4.1550    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1560    5.0480    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1430    3.6880   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0570    2.8440   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8980    1.3690   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.9120   -0.9120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9930    4.5450    2.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    3.1990    2.3250 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    5.3950    3.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5700    6.7730    2.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7380    7.2990    1.8660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    8.6620    1.8000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1970    9.1930    0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720    8.8030    1.0190 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.1960    8.8320   -0.4300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1570   10.5420    0.8830 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0390    6.4310    1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 16  1  0  0  0  0
 11 26  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 20 26  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 22 24  1  0  0  0  0
 22 25  1  0  0  0  0
M  END
>  <ID>
CP_125_611

> <PRIMARY_SOM>
8

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
CP_677_623
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.8080    3.8640    0.5460 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4930    4.1910    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2830    5.0800    0.9350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2670    4.5630    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    3.2130    1.7300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910    2.8110    2.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9700    5.4250    2.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    6.7920    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250    7.3130    1.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5390    8.6650    1.8480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4560    9.2040    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6730    8.6930    1.2710 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560    8.9780   -0.3070 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5090   10.5410    1.1800 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    6.4530    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3 15  2  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
M  END
>  <ID>
CP_677_623

> <PRIMARY_SOM>
6

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
DDTC_Me
  MOE2008           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  5  1  0  0  0  0
  3  4  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
DDTC_Me

> <PRIMARY_SOM>
6 7

>  <Citation>
Madan et al.,Alcohol. Clin. Exp. Res.,22,1212,1998

>  <DOI>
10.111/j.1530-0277.1998.tb03901.x

$$$$
DETC_Me
  MOE2008           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  5  1  0  0  0  0
  3  4  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
DETC_Me

> <PRIMARY_SOM>
8

>  <Citation>
Madan et al.,Drug Metab. Disp.,23,1153,1995

$$$$
DMBA
  MOE2008           2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  1  0  0  0  0
  2 15  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  6 20  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 13 19  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
DMBA

> <PRIMARY_SOM>
3 4

> <SECONDARY_SOM>
8 9 19 20

> <TERTIARY_SOM>
15 16 17

>  <Citation>
Shou, M.; Korzekwa, K.R.; Krausz, K.W.; Buters, J.T.; Grogan, J.; Goldfarb, I.; Ardwick, J.P.H.; Gonzalez, F.J.; Gelboin, H.V. Specificity of cDNA-Expressed Human and Rodent Cytochrome P450s in the Oxidative Metabolism of the Potent Carcinogen 7,12-Dimethylbenz[a]anthracene. Mol. Carcinog. 1996, 17, 241~249. 

>  <DOI>
10.1002/(SICI)1098-2744(199612)17:4<241::AID-MC8>3.0.CO;2-G

$$$$
KR_31543
  MOE2008           3D

 33 36  0  0  1  0  0  0  0  0999 V2000
    1.0150    1.1300   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2220    1.7620    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090    1.0890    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5460    1.7390    0.8530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1570   -0.2340    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0750   -0.8700    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590   -0.1840    0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390   -0.8740    0.3750 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5270   -0.0540    0.2840 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.6600   -1.0050   -0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8100    0.6000    1.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9170   -0.4100    2.6570 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3930    0.1030    3.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9870    1.3930    1.6100 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750    2.4350    2.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3710    0.9490   -0.8510 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.5380    1.7130   -1.0970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1730    1.8490   -0.6210 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.8230    2.6560   -1.7830 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.4620    2.1370   -3.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8320    4.1040   -1.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.7500   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3980    0.7570   -3.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0320    0.2260   -4.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190    1.0870   -5.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2660    0.4480   -7.0470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7700    2.4620   -5.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1380    2.9710   -4.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.5820    0.6260 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8540    5.2830    1.0850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4040    5.8260   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5740    6.6630    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8060    5.5510   -1.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  1 18  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 16  1  0  0  0  0
 11 12  1  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 23  1  0  0  0  0
 20 28  2  0  0  0  0
 21 22  1  0  0  0  0
 22 29  1  0  0  0  0
 22 33  2  0  0  0  0
 23 24  2  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 25 27  2  0  0  0  0
 27 28  1  0  0  0  0
 29 30  2  0  0  0  0
 30 31  1  0  0  0  0
 31 32  1  0  0  0  0
 31 33  1  0  0  0  0
M  END
>  <ID>
KR_31543

> <PRIMARY_SOM>
18

>  <Citation>
Ji et al,Arch. Pharm. Res.,27,239,2004

$$$$
MBDB
  MOE2008           3D

 15 16  0  0  1  0  0  0  0  0999 V2000
    3.6900    1.4860   -0.3990 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3880   -0.5360    0.7140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2280   -0.7890    0.6660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9130    0.1540   -0.3960 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.8110   -0.3000   -1.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6550    1.5460    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640   -0.3930   -0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4440    0.6850   -0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210    2.0830    0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -1.5740   -0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7100    0.5470   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070   -0.6060    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650   -1.6900    0.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6470   -2.0520    0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7440    0.7980    0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0  0  0  0
  1 15  1  0  0  0  0
  2 12  1  0  0  0  0
  2 15  1  0  0  0  0
  3  4  1  0  0  0  0
  3 14  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  9  1  0  0  0  0
  7  8  2  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
 10 13  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
MBDB

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
15

>  <Citation>
Meyer et al.,Biochem. Pharma.,77,1725,2009

>  <DOI>
10.1016/j.bcp.2009.03.001

$$$$
MEXILETINE
  MOE2008           3D

 13 13  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.0910    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0480    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920   -0.7760    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4130   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    3.5980    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5560    2.2420    1.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8890    2.9890    1.4710 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.7930    4.2920    0.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9560    2.1500    0.9100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  7 10  1  0  0  0  0
  9 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
MEXILETINE

> <PRIMARY_SOM>
13

>  <Citation>
L. LABBE, Z. ABOLFATHI, E . LESSARD, H. PAKDEL, P. BEAUNE and J. TURGEON, xenobiotica, 2003, vol. 33, no. 1, 13-25 

>  <DOI>
10.1080/0049825021000017948

$$$$
NDEA
  MOE2008           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
   -1.4200    2.1290    0.5220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.7790    1.2100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3770    3.4350    0.4020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0280    3.8820    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4090    3.6260   -1.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2950    3.9590   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7110    4.0650   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
NDEA

> <PRIMARY_SOM>
4 6

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NDPA
  MOE2008           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -1.4550    2.1300    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460    1.7980    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400    3.4350    0.4460 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    3.8240    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    4.0590   -0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4580    3.6160   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8900    4.0580   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    4.2180   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4940    4.8650   -1.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
NDPA

> <PRIMARY_SOM>
4 5

>  <Citation>
Teiber et al., Carcinogenesis, 2000, 21, 1559-1566

$$$$
NMBA
  MOE2008           3D

  8  7  0  0  1  0  0  0  0  0999 V2000
   -1.4650    2.1740    0.6830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6120    1.8440    1.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3880    3.4570    0.4440 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0270    3.8870    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    3.9110   -0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4850    3.5250   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9000    4.0240   -1.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4100    3.6640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
NMBA

> <PRIMARY_SOM>
4 5

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NMEA
  MOE2008           3D

  6  5  0  0  1  0  0  0  0  0999 V2000
   -1.3300    2.1530    0.6200 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160    1.6620    0.9520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    3.4330    0.3750 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.3870    3.7480   -0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1580    4.0560    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000    3.7680   -1.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
NMEA

> <PRIMARY_SOM>
4 5

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NN_dimethyl_M_toluamide
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.1290    1.5810    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    1.2190    2.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1550    0.6120    2.9330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1900    0.3630    2.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    0.7200    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180    1.3260    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690    2.2250    0.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    4.8880    1.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2880    4.8280    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2940    0.2200    4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
NN_dimethyl_M_toluamide

> <PRIMARY_SOM>
14

>  <Citation>
Usmani et al.,Drug Metab. Disp.,30,289,2002

>  <DOI>
10.1124/dmd.30.3.289

$$$$
N_nitrosodiamylamine
  MOE2008           3D

 13 12  0  0  0  0  0  0  0  0999 V2000
   -0.0150    1.2860    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -0.6270    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430    2.0350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.0010    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950    2.2890    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7460    2.2580   -1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0100    3.0720    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0810    3.0050   -1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4620    3.3250    2.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5330    3.2620   -2.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7760    4.1080    2.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8680    4.0080   -2.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  2  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
N_nitrosodiamylamine

> <PRIMARY_SOM>
10 11

> <SECONDARY_SOM>
8 9

> <TERTIARY_SOM>
6 7 12 13

>  <Citation>
Bellec et al.,Mutation Res.,377,199,1997

>  <DOI>
10.1016/S0027-5107(97)00073-0

$$$$
RP73401
  MOE2008           3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    1.0190    0.5080   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2500    0.4240    0.6610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1150    1.2270    0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470    2.0740    1.8530 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310    1.1940   -0.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    0.5170   -1.6160 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2240   -0.1940   -1.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9370   -0.2360   -1.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2380   -1.1990   -1.8020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.8400    1.1050    1.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1440    0.5270    2.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    2.1170    2.2560 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8610    1.1480    3.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0920    0.6380    3.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8320    1.2150    4.5470 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2120    2.3630    5.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6090   -0.5120    2.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8200   -0.9800    3.3720 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2270   -2.1460    2.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8840   -1.1300    1.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6580   -0.6160    1.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9850    3.6500    4.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1020    4.5080    5.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2970    3.6900    7.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9730    2.2700    6.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  8  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  1  0  0  0  0
 11 21  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 22  1  0  0  0  0
 16 25  1  0  0  0  0
 17 18  1  0  0  0  0
 17 20  2  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
RP73401

> <PRIMARY_SOM>
23 24

>  <Citation>
Stevens et al.,J. Pharma. Exp. Thera.,282,1389,1997

$$$$
R_95913
  MOE2008           3D

 23 26  0  0  1  0  0  0  0  0999 V2000
   -0.5810    3.2360    0.9080 N   0  0  3  0  0  0  0  0  0  0  0  0
    0.7980    3.2870    1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5910    4.0970    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5960    3.6360   -1.0130 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.1290    3.5480   -1.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    2.6380   -0.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950    2.4310    1.8330 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5420    1.4680    2.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4110    1.6110    4.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3920    0.7270    4.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0600   -0.3070    4.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9260   -0.4550    2.7030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1260    0.4320    1.9690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3810    1.6470    1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9990    0.9700    0.0820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8380    1.6720    1.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8040    1.1210    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5160    0.3070    1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    2.5940    4.6520 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.3280    5.2900    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5310    4.9620   -1.7970 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.9290    5.9190   -0.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6080    6.9700   -0.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3 20  2  0  0  0  0
  4  5  1  0  0  0  0
  4 21  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  7 14  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  2  0  0  0  0
  9 19  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 18  1  0  0  0  0
 20 22  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  2  0  0  0  0
M  END
>  <ID>
R_95913

> <PRIMARY_SOM>
21

>  <Citation>
Rehmel et al.,Drug Metab. Dispos.,34,600,2006

$$$$
acetochlor
  MOE2008           3D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -1.8590   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6210    0.2760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8590   -1.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1000    0.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6210    1.7070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6210   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1000   -2.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6210   -2.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3410   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1000    1.7070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6170    2.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8620    2.4240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8620    0.2760    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3410   -1.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0020   -2.9480   -1.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8590    1.7070    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.1030   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3410    0.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  2  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8 15  1  0  0  0  0
  9 14  1  0  0  0  0
 11 16  1  0  0  0  0
 13 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
acetochlor

> <PRIMARY_SOM>
17

>  <Citation>
Coleman et al.,Env. Health Perspec.,108,1151,2000
Coleman et al.,Chem. Biol. Inter.,122,27,1999

$$$$
alachlor
  MOE2008           3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.1780    1.7180    0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790    0.4240    0.6430 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0430    2.7620    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1840    1.9600    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9680   -0.0190    1.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8890   -0.4490   -0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5460    4.0380   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5210    2.5040    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6750    3.2380    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    0.8280    0.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3800   -1.4530    2.0930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8950    0.7370    2.8290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3720   -0.9230   -0.9890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8110    4.2770    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8710    2.2820   -1.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1830    0.6260    2.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5550   -1.7750    3.8590 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.8850    0.0780   -1.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  2  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8 15  1  0  0  0  0
  9 14  1  0  0  0  0
 10 16  1  0  0  0  0
 11 17  1  0  0  0  0
 13 18  1  0  0  0  0
M  END
>  <ID>
alachlor

> <PRIMARY_SOM>
18

>  <Citation>
Coleman et al.,Env. Health Perspec.,108,1151,2000
Coleman et al.,Chem. Biol. Inter.,122,27,1999

$$$$
ametryne
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0540   -1.5120   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190   -0.7170   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9630    0.6030   -0.0800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2590    1.1280   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3240    0.3330   -0.0230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680   -0.9870   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2730   -1.8130    0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6190   -1.2340    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6560   -2.3580    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870   -1.2620   -0.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5600   -0.3870   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0010   -0.0580    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000   -1.0950   -0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4660    2.8780   -0.0840 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2730    2.9810   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
ametryne

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
11

>  <Citation>
Lang et al.,Chem. Res. Tox.,10,1037,1997

$$$$
aminopyrine
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
    1.2340    0.6640   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720    1.3640    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1000    0.6680    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030   -0.7260    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0540   -1.4490    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -2.8580    0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -0.7300   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -3.6770    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410   -3.3550    0.6360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -5.1190    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300   -6.2220    0.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8290   -6.1260    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350   -7.5700    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750   -5.0000   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -3.6910   -0.1960 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.4120   -3.2500   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 15  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 14  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
aminopyrine

> <PRIMARY_SOM>
12 13

>  <Citation>
Niwa et al.,Xenobiotica,29,187,1999

>  <DOI>
10.1080/004982599238731

$$$$
amitriptyline
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.5320   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0940   -0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410    2.2850    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1220    2.1320   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000   -0.4150   -1.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7770   -0.7760    0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    2.0220   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3650    3.2740    1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4640    3.5550    0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5310    0.4770   -2.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6080   -1.7700   -1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8610   -2.1290    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7370    0.9930   -1.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6880    2.7600   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5130    4.0030    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1970    4.1140   -0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1690   -2.6260   -1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6820    3.7450    0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5560    5.5090   -0.7940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1630    5.9650   -2.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5830    5.5890    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 13  1  0  0  0  0
 11 17  2  0  0  0  0
 12 17  1  0  0  0  0
 14 18  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
amitriptyline

> <PRIMARY_SOM>
20 21

>  <Citation>
S. Ekins et al., J. Pharm. Exp. Ther., 1999, 288, 21-29

$$$$
antipyrine
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -0.5220    2.9500    0.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2640    0.5920   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370   -0.4150   -0.1310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4770    0.1550    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    0.4060    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    1.8060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900    1.4870    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9690   -1.7690   -0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370   -0.6370    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9960    1.4380   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7270   -0.7690    0.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3860    1.2840   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1170   -0.9260    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9470    0.0990    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  4  1  0  0  0  0
  3  8  1  0  0  0  0
  4  7  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6  7  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
antipyrine

> <PRIMARY_SOM>
7

>  <Citation>
G. Engel, U. Hofmann, H. Heidemann, J. Cosme, M. Eichelbaum, Clin. Pharmacol. Ther. 1996, 59, 613-623.

$$$$
arachidonic_acid
  MOE2008           3D

 22 21  0  0  0  0  0  0  0  0999 V2000
   10.1270    3.3080   -2.6290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8510    4.8200   -0.9420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710    1.5580    1.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7460    0.7020    1.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    0.8720    0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100    1.4510    3.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    0.4310   -0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1120    0.5960    3.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4170    1.7080   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4690    0.6900    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050   -0.8280   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010   -1.9960   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6380    2.7370   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2360   -0.3180    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470   -2.3160   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2990   -2.6660   -1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2270   -1.6330    1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4220   -2.2230   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6240   -2.7690   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5070   -3.3210    0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1780   -3.2830    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5920    3.7460   -1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 11  2  0  0  0  0
  9 10  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 12 16  1  0  0  0  0
 13 22  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 15 20  1  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 20 21  2  0  0  0  0
M  END
>  <ID>
arachidonic_acid

> <PRIMARY_SOM>
6

> <SECONDARY_SOM>
7 11

>  <Citation>
Rifkind et al.,Arch. Biochem. Biophys.,320,380,1995

>  <DOI>
10.1016/0003-9861(95)90023-3

$$$$
atomoxetine
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -0.1900    1.2080    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3720   -0.1630    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070   -1.0030    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9680   -0.4740    0.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500    0.8970    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0710    1.7370    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3650    2.1240    0.0110 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2050    3.3050    0.7980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6370    3.0040    2.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9860    1.7000    2.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190    1.3940    3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5040    2.3870    4.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1580    3.6880    4.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7240    3.9980    3.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460    5.4160    2.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    2.5040   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7030    3.3320   -1.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7760    3.6970   -3.1410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0030    4.4850   -3.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
atomoxetine

> <PRIMARY_SOM>
12

> <SECONDARY_SOM>
19

>  <Citation>
Ring et al.,30,319,2002

>  <DOI>
10.1124/dmd.30.3.319

$$$$
atrazine
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.2530   -1.3280    0.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8930   -0.6570    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8830    0.6740    0.0820 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2670    1.3280    0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100    0.6630    0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4060   -0.6680    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5990   -1.3610   -0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8700   -0.6330   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0290   -1.6300   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930   -1.3390    0.0770 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.5980    0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4110   -1.4290    0.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8290   -0.3160   -1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2760    3.0640    0.0950 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
atrazine

> <PRIMARY_SOM>
8 11

>  <Citation>
Lang et al.,Chem. Res. Toxicol.,10,1037,1997

$$$$
benzphetamine
  MOE2008           3D

 18 19  0  0  1  0  0  0  0  0999 V2000
   -0.1940    0.2330    1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0510    1.1920   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0510    2.6340    0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910    3.5690   -0.5530 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.1310    3.4320   -0.4010 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.6770    4.1680    0.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    3.6940   -1.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8060    5.0730   -2.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1820    4.9780   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0640    0.7800   -1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -0.5750   -1.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0900   -1.5270   -0.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2120   -1.1230    0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9230    5.3530   -3.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8720    6.6300   -3.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7080    7.6320   -3.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5970    7.3560   -2.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6470    6.0780   -1.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 13  2  0  0  0  0
  2  3  1  0  0  0  0
  2 10  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8 14  1  0  0  0  0
  8 18  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
benzphetamine

> <PRIMARY_SOM>
6

>  <Citation>
Ekins et al.,Drug Metab. Rev.,31,719,1999

$$$$
beta_arteether
  MOE2008           3D

 23 26  0  0  1  0  0  0  0  0999 V2000
    5.3750   -0.6010   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1230    0.0890   -1.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3790    0.6510    0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2290    1.2780   -0.5340 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.4530    0.2970   -1.2410 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3860    1.9130    0.5890 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0570    1.8910    0.1540 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.5520    1.1080    1.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6950   -0.3980   -0.2570 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5500    0.4270    0.0800 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.0740    2.6700    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1830   -1.6490   -0.6550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6650    0.4830   -0.9430 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.9080   -0.0450    1.3610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950    2.6400    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8140    1.2190   -0.1740 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.0310   -1.4620    1.3990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0700    1.2500   -1.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2460   -0.8390   -1.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4280   -2.3130    0.4300 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.7570   -2.8890   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6910   -1.7840   -0.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4860   -3.3680    1.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  9  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 10 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 15  1  0  0  0  0
 12 20  1  0  0  0  0
 13 16  1  0  0  0  0
 13 19  1  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 20  1  0  0  0  0
 19 22  1  0  0  0  0
 20 21  1  0  0  0  0
 20 23  1  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
beta_arteether

> <PRIMARY_SOM>
2

>  <Citation>
J.M. Grace et al., Drug Metab. Dispos., 1998, 26, 313-317

$$$$
bupropion
  MOE2008           3D

 16 16  0  0  1  0  0  0  0  0999 V2000
   -2.7640    0.4950   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6190   -0.5240   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1440   -1.8160   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8150   -2.0980   -0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9450   -1.0750    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300    0.2280    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4750   -1.3680    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4100   -0.2620    0.6860 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.4240   -0.1570    2.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7650   -0.5580    0.2030 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2570    0.6630   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000    0.4500   -0.9090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780    0.9830   -1.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2040    1.8280    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3680    2.1130    0.1000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8930   -2.4990    0.1390 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 15  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
M  END
>  <ID>
bupropion

> <PRIMARY_SOM>
14 13 12

>  <Citation>
Faucette et al.,Drug Metab. Disp.,29,1123,2001

$$$$
butachlor
  MOE2008           3D

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0540    2.1270    1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3910    0.7400    0.9720 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9890    3.1010    0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2240    2.5560    1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -0.1550    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0790    0.2830   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6520    4.4610    0.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    2.7580    0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5330    3.9240    1.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3230    1.5880    1.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4100   -1.5990    1.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3670    0.1500    3.1010 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2000   -0.5570   -0.9550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6030    4.8750    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7310    3.2720   -1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2090    2.0420    2.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0470   -1.9380    2.3040 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6660   -0.6180   -2.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3380    0.6050   -3.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6150    1.5840   -2.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8380    2.7540   -3.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  2  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8 15  1  0  0  0  0
  9 14  1  0  0  0  0
 10 16  1  0  0  0  0
 11 17  1  0  0  0  0
 13 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
butachlor

> <PRIMARY_SOM>
18

>  <Citation>
Coleman et al.,Env. Health Perspec.,108,1151,2000
Coleman et al.,Chem. Biol. Inter.,122,27,1999

$$$$
capsaicin
  MOE2008           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    2.0890    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.1120    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    1.4200   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7530    2.3420    1.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    0.0350   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -2.0400   -0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9090    2.9870    1.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5940   -0.6250   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1300   -2.4740   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3410    3.2240    3.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6020    3.3760    0.7430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6770    3.9690    3.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1160    4.2090    4.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4520    4.9540    4.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8840    5.1910    5.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1560    6.4060    6.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5880    6.6430    7.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5940    7.5840    8.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9810    7.2760    7.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 10 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
capsaicin

> <PRIMARY_SOM>
2 3 4 6 7

>  <Citation>
Reilly et al.,Chem. Res. Toxicol.,16,336,2003

>  <DOI>
10.1021/tx025599q

$$$$
carbaryl
  MOE2008           3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0060    1.3790    0.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0010   -0.0010   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2280    2.0940    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1750    2.0600    0.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1620   -0.7040    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1680   -0.6260   -0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4090    1.4140   -0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360    3.4700    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1300    3.3930    0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1420   -2.0460   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.0810   -0.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730    4.0950    0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2980   -2.7320   -0.1950 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0810   -2.6390   -0.1140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2760   -4.1920   -0.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  1  0  0  0  0
  7 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 12  2  0  0  0  0
 10 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  1  0  0  0  0
M  END
>  <ID>
carbaryl

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
7

>  <Citation>
Tang et al,Chem. Biol. Inter.,141,229,2002

>  <DOI>
10.1016/S0009-2797(02)00074-1

$$$$
chlorpromazine
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    9.2890    0.0450    0.1860 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.7020   -4.2120    0.6280 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.3510   -1.2390   -0.3250 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    3.3000    1.1460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1790    0.1510   -0.7280 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8570    1.0080    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6660    2.4360    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6520   -1.6350    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -2.0440   -0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9350   -2.9400    0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2290   -3.3890    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7240   -0.7300   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620   -1.5230   -0.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2430   -3.3030    0.8170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0610   -4.1620    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2770    4.6550    0.6310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0350    2.9650    1.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0190   -1.1010    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8020   -2.2930   -0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2870   -2.3890    0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -3.6200   -0.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0  0  0  0
  2 10  1  0  0  0  0
  2 11  1  0  0  0  0
  3  5  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  7  1  0  0  0  0
  4 16  1  0  0  0  0
  4 17  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8 10  2  0  0  0  0
  8 12  1  0  0  0  0
  9 11  2  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 15  1  0  0  0  0
 12 18  2  0  0  0  0
 13 19  2  0  0  0  0
 14 20  2  0  0  0  0
 15 21  2  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
chlorpromazine

> <PRIMARY_SOM>
2

>  <Citation>
Cashman et al.,Drug Metab. Disp.,21,492,1993

$$$$
chlorpyrifos
  MOE2008           3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.1140    1.5240    0.0170 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1110   -0.0700    0.0480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6920    1.8420   -0.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5980    2.1420   -1.2880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270    2.2860    1.5480 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2010   -0.4860    1.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2140    1.1690   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    3.5590   -1.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7860   -0.5280    2.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4410   -0.8520    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7330    1.3420   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1590    4.2220   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4550   -0.9550    3.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4130   -0.0510    1.9050 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.7880   -1.2630    2.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8590   -1.3260    3.8080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4320   -1.7320    3.0910 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3280   -1.8680    5.3880 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
  9 14  1  0  0  0  0
 10 15  2  0  0  0  0
 13 16  2  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
M  END
>  <ID>
chlorpyrifos

> <PRIMARY_SOM>
1 5

>  <Citation>
Tang et al.,Drug Metab. Disp.,29,1201,2001

$$$$
chlorzoxazone
  MOE2008           3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.3330    0.6250    0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2120    1.4210    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0080    0.7740   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5940   -1.3800   -0.3940 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0710   -0.6280   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710   -1.4210   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530   -0.7460    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5300   -1.2400    0.3190 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.1320    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5690   -0.1620    0.6630 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250    1.0690    0.4690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
chlorzoxazone

> <PRIMARY_SOM>
3

>  <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

$$$$
cinnarizine
  MOE2008           3D

 28 31  0  0  0  0  0  0  0  0999 V2000
    1.1320    0.9920   -0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0250    1.8260    0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3470    1.5790    1.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    2.4540    2.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3200    1.7240    3.0750 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5230   -0.1590    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3250   -0.9210   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5710   -0.5360   -2.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    0.6090   -2.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8800    1.3700   -1.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7670    1.0570    4.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8250    0.5130    5.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8390    1.4760    5.6370 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2170    2.4860    6.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4580    1.9350    7.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1060    3.6420    6.8780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3760    2.1230    4.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3430    2.6820    3.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070    2.2600    7.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    1.7720    8.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870    0.9560    9.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3340    0.6270    9.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0670    1.1160    8.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6910    4.9370    6.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4860    6.0320    6.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7000    5.8380    7.5440 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1210    4.5510    7.8670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3260    3.4560    7.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5 11  1  0  0  0  0
  5 18  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 17  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 19  1  0  0  0  0
 15 23  2  0  0  0  0
 16 24  1  0  0  0  0
 16 28  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 22 23  1  0  0  0  0
 24 25  2  0  0  0  0
 25 26  1  0  0  0  0
 26 27  2  0  0  0  0
 27 28  1  0  0  0  0
M  END
>  <ID>
cinnarizine

> <PRIMARY_SOM>
21 26

>  <Citation>
S. Kariya, S. Isozaki, K. Uchino, T. Suzuki, S. Narimatsu, Biol. Pharm. Bull. 1996, 19, 1511-1514.

$$$$
cisapride
  MOE2008           3D

 32 34  0  0  1  0  0  0  0  0999 V2000
    6.4190   -0.0900   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5750   -0.1140   -1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6100   -0.9640   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4940   -1.7920    0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3410   -1.7680    1.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040   -0.9190    0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5060   -2.6230    0.7170 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4020    0.7500   -0.6200 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3680    0.5450    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1870    1.4650    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0800    1.2450    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0020    2.2180    0.8400 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0620    1.8950    1.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.8670    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7950    2.7230    0.2040 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.6650    2.9380   -0.8070 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.4740    1.9620   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550    2.7050   -2.1290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3970    3.5420   -3.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3590    1.3820    0.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6540    1.1530    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3540    2.0600    0.7390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2200   -0.1950    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5700   -0.4350    0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0930   -1.7060    0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2820   -2.7350   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9420   -2.4920   -0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4170   -1.2410   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9370   -3.7860   -1.0340 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.8080   -4.0130   -0.3230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3570    0.5740    0.9140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6570    0.0190    1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  8  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 20  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 21 23  1  0  0  0  0
 23 24  1  0  0  0  0
 23 28  2  0  0  0  0
 24 25  2  0  0  0  0
 24 31  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  2  0  0  0  0
 26 30  1  0  0  0  0
 27 28  1  0  0  0  0
 27 29  1  0  0  0  0
 31 32  1  0  0  0  0
M  END
>  <ID>
cisapride

> <PRIMARY_SOM>
11

>  <Citation>
Desta et al.,Drug Metab. Disp.,28,789,2000

$$$$
clobazam
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.3440    1.2520    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5340    2.3210    0.5630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6610    1.4170    0.9300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9330   -0.6520   -0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1460   -0.6410    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8610    2.2590    0.1480 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0890    3.5420    1.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    2.6280    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7930   -1.5980   -0.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0070   -0.3460   -2.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2360   -0.0070    1.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3140   -1.7530   -0.2150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6940    1.2440    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    3.4120   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    3.6940    1.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7300    2.8140    1.9690 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7150   -2.2350   -1.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9310   -0.9870   -2.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8430    1.3260   -0.0180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7820   -1.9320   -2.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  7 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 16  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 11 19  2  0  0  0  0
 12 14  1  0  0  0  0
 14 20  2  0  0  0  0
 18 21  2  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
clobazam

> <PRIMARY_SOM>
15

>  <Citation>
Giraud et al.,Drug Metab. Disp.,32,1279,2004

$$$$
clopidogrel
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    1.0800    0.5470    1.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5140    0.7390    2.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410   -0.4490    3.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4570   -1.7960    2.1930 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000   -0.7920    0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6670   -1.3110   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8940   -0.1450   -1.2510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.0160   -0.5910 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.8700    2.0010   -1.6110 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.9520    2.9550   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5730    1.6000    0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2270    2.8690   -1.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6060    1.6760   -2.9660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.2350    3.7580   -1.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9790    4.7450   -0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170    4.8440    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7120    3.9550   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    2.6380   -2.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8490    3.3520   -1.8210 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7480    2.2880   -3.6510 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6710    2.8660   -4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 18  1  0  0  0  0
 10 12  1  0  0  0  0
 10 17  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
clopidogrel

> <PRIMARY_SOM>
3

>  <Citation>
Kazui et al., Drug Metab. Dispos.,2010, 38, 92-99

>  <DOI>
10.1124/dmd.109.029132

$$$$
clotiazepam
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.2680    0.9740    1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6310    1.9650    2.8520 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0120    1.4890    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050    2.9330   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3550    0.6300   -0.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3970   -0.7450   -0.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1040   -1.2620    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2240   -0.4040    1.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750    3.6420    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4150    4.9500    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4530    5.9010    0.8000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7120    7.0260    1.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8390    5.8120    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7740    6.5090    0.6910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120    4.8820   -0.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980    3.4920   -0.4500 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5600    3.0550   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6080    3.8920    0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0590    3.6220    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5510    3.8140   -1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0540    5.3920    0.6900 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  8  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  4  9  1  0  0  0  0
  4 16  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
  9 17  1  0  0  0  0
 10 11  1  0  0  0  0
 10 21  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 13 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
clotiazepam

> <PRIMARY_SOM>
12 19

>  <Citation>
Mandrioli et al.,Curr. Drug Metab.,9,827,2008
Niwa et al.,Biol. Pharm. Bull.,28,1711,2005

$$$$
cyamemazine
  MOE2008           3D

 23 25  0  0  1  0  0  0  0  0999 V2000
   -3.3570    0.0250   10.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8590   -0.1810   10.5240 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.1610    0.6370    9.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3990    0.1090    8.1170 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.3150    0.8260    7.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8930    2.0180    7.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7980    2.7530    7.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1480    2.3060    5.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5880    1.1320    5.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6770    0.3920    6.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0430   -1.0890    5.2830 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8840   -1.6690    6.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6870   -1.0450    7.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2630   -1.6140    8.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9850   -2.7550    8.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7760   -3.3610    7.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560   -2.8170    6.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9330   -3.2960    9.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7020   -3.7330    9.9360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2780    0.1980   11.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8250   -0.5700   12.9760 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4030   -1.9540   12.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2150   -0.0600   14.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4 13  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 18  1  0  0  0  0
 16 17  1  0  0  0  0
 18 19  3  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 23  1  0  0  0  0
M  END
>  <ID>
cyamemazine

> <PRIMARY_SOM>
22 23

> <SECONDARY_SOM>
11

>  <Citation>
Arbus et al., European Journal of Pharmaceutical Sciences, 2007, 32, 357-366

>  <DOI>
10.1016/j.ejps.2007.09.003

$$$$
cyclophosphamide
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -0.7780    0.0140   -0.1410 P   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5870   -1.4430   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8170   -0.0400    0.3800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5790    1.0700    0.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    0.4520   -1.6500 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060    1.2460   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5660   -1.1520   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6400    2.7520   -0.2330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.4840   -1.8010    2.2750 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.9730   -1.2560   -0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6630   -0.1860    0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9450    1.1760    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6810   -2.3340    0.7690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8940    1.2600    0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2 10  1  0  0  0  0
  3  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4 12  1  0  0  0  0
  6 14  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
  9 13  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
cyclophosphamide

> <PRIMARY_SOM>
10

>  <Citation>
Roy et al.,Drug Metab. Disp.,27,655,1999

$$$$
delta3_carene
  MOE2008           3D

 10 11  0  0  1  0  0  0  0  0999 V2000
    0.1120    1.2960   -0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2050   -0.0380   -0.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.8210    0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3010   -0.0560    0.9880 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.2040    1.4460    1.0530 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.1120    2.1460    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0090    2.0060   -1.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3640    0.7960    0.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4410    0.8650   -1.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6850    0.8530    1.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
M  END
>  <ID>
delta3_carene

> <PRIMARY_SOM>
7

>  <Citation>
Duisken et al.,Curr. Drug. Metab.,6,593,2005

>  <DOI>
10.2174/138920005774832614

$$$$
demethyl-sibutramine
  MOE2008           3D

 18 19  0  0  1  0  0  0  0  0999 V2000
    6.0940   -4.4930    0.6920 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4300    3.2550    0.8760 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0310    1.5120    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2930    2.1040   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1710    2.4240    0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6520    1.8470    0.5830 C   0  0  3  0  0  0  0  0  0  0  0  0
    6.5970    2.7250   -0.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3110   -0.0510    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5460    1.1440   -0.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2240    1.0050    0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6480   -0.6060    1.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2300   -0.9500   -0.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0900    4.0000   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2940    0.1600   -0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5490    2.3210    0.8310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8910   -1.9690    1.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4690   -2.3150   -0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7990   -2.8160    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0  0  0  0
  2  6  1  0  0  0  0
  2 13  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  3  8  1  0  0  0  0
  4  7  1  0  0  0  0
  5  7  1  0  0  0  0
  6  9  1  0  0  0  0
  8 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 14  1  0  0  0  0
 10 15  1  0  0  0  0
 11 16  1  0  0  0  0
 12 17  2  0  0  0  0
 16 18  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
demethyl-sibutramine

> <PRIMARY_SOM>
13

>  <Citation>
Bae et al.,Drug Metab. Disp.,36,1679,2008

>  <DOI>
10.1124/dmd.108.020727

$$$$
dexloxiglumide
  MOE2008           3D

 30 30  0  0  1  0  0  0  0  0999 V2000
    0.0170    0.4640    1.5970 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0340   -0.7080    0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410    1.0870    1.5300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2470   -0.0210    3.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -1.0800    0.1010 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9800   -1.3180    0.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4920    2.3850    1.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440    1.1840    3.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4290   -0.3310    0.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2610   -2.2320   -0.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8280    3.0140    1.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5300    3.0380    2.2140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6040    0.7070    5.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8160    0.5280   -0.7990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5310   -3.5020    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870    4.3580    2.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9360    2.2640    1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7270    1.5960    6.3660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7030   -0.4750    5.5950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1740    1.1850   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5870   -4.7060   -0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2380    4.9400    2.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1800    2.8560    1.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5600    2.0440   -1.7470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8390   -5.8920   -0.1810 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3320    4.1910    1.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4380    6.6110    2.4940 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.9180    2.7010   -1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8800   -6.9740   -1.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9020    4.9290    1.5890 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 12  2  0  0  0  0
  8 13  1  0  0  0  0
  9 14  1  0  0  0  0
 10 15  1  0  0  0  0
 11 16  2  0  0  0  0
 11 17  1  0  0  0  0
 13 18  1  0  0  0  0
 13 19  2  0  0  0  0
 14 20  1  0  0  0  0
 15 21  1  0  0  0  0
 16 22  1  0  0  0  0
 17 23  2  0  0  0  0
 20 24  1  0  0  0  0
 21 25  1  0  0  0  0
 22 26  2  0  0  0  0
 22 27  1  0  0  0  0
 23 26  1  0  0  0  0
 24 28  1  0  0  0  0
 25 29  1  0  0  0  0
 26 30  1  0  0  0  0
M  END
>  <ID>
dexloxiglumide

> <PRIMARY_SOM>
29

>  <Citation>
Hall et al.,Biopharm Drug Disp.,25,163,2004

$$$$
dextromethorphan
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   -2.7290   -0.1730    0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5950    0.4630    0.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6040   -1.1610   -0.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3580   -1.4930   -1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190   -0.8530   -0.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3420    0.1150    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8640    0.8030    0.7650 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.5260    2.2330    1.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1110    3.0230   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2540    3.0160   -1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5800    1.5740   -1.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0060    0.7900   -0.2560 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.2810   -0.6660   -0.6260 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.1060   -1.2490   -1.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6460   -1.4610    0.5360 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.3180   -0.0050    1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5560   -1.4440    1.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7770   -2.8490    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9550    0.1640    0.6610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9040   -0.6620   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1 19  1  0  0  0  0
  2  6  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 14  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 17  1  0  0  0  0
 15 18  1  0  0  0  0
 16 17  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
dextromethorphan

> <PRIMARY_SOM>
18

>  <Citation>
Y. Wang, J.D. Unadkat, Biopharm. Drug Dispos., 1999, 20, 341-346

$$$$
diazepam
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.6960   -2.6210    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480   -1.4280    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6990   -0.2110    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3780   -0.2110   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2740   -1.4340   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3840   -2.6240   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4340   -4.1300   -0.4890 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3810    1.0230   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4190    0.9480    0.4870 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2840    0.9660    1.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1000    2.9820    0.0240 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870    2.0450   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    2.1530   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0960    2.0770   -1.0260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8020    1.0530   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2530    0.2050    0.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6940    1.9320   -0.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5780    0.2380    1.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0160    1.9560   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4580    1.1090    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  2  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8 14  2  0  0  0  0
  8 15  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 15 16  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
diazepam

> <PRIMARY_SOM>
10

>  <Citation>
Yang et al.,Drug Metab. Disp.,27,102,1999

$$$$
diazinon
  MOE2008           3D

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.1120    1.8800    0.2270 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6470    0.6190    0.8930 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640    1.2210   -0.3820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7740    2.1030   -1.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3540    3.4620    1.3280 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1590   -0.0970    1.9520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    0.0920   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2940    3.0640   -2.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9650   -1.0970    2.3550 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0590    0.1820    2.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6810   -0.3870   -1.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    3.0950   -3.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5240   -1.8370    3.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3790   -2.9580    3.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7070   -2.4430    4.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5890   -3.9920    2.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4160   -0.6350    3.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7160   -0.4040    4.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6460   -1.6480    4.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 10 17  2  0  0  0  0
 13 14  1  0  0  0  0
 13 19  2  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
diazinon

> <PRIMARY_SOM>
1 5

>  <Citation>
Mutch et al.,Toxicology,224,22,2006

>  <DOI>
10.1016/j.tox.2006.04.024

$$$$
dibenzo_a_h_anthracene
  MOE2008           3D

 22 26  0  0  0  0  0  0  0  0999 V2000
    2.4280    1.4740    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500    0.7620    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6510   -0.6300    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520   -1.3350    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360   -0.6560    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -1.3850    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -0.7540    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4280   -1.4730    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6500   -0.7610   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6510    0.6310   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4520    1.3350   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    0.6570   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0470    1.3850   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    0.7550    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8650    1.4450    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8930    2.8370    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7020    3.5540    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4850    2.8770    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8650   -1.4450   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8930   -2.8370   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7020   -3.5540    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850   -2.8770    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 18  2  0  0  0  0
  2  3  1  0  0  0  0
  2 15  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 12  1  0  0  0  0
  8  9  1  0  0  0  0
  8 22  2  0  0  0  0
  9 10  1  0  0  0  0
  9 19  2  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
dibenzo_a_h_anthracene

> <PRIMARY_SOM>
15 16 19 20

> <SECONDARY_SOM>
17 18 21 22

> <TERTIARY_SOM>
3 4 10 11

>  <Citation>
Shou, M.G.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,h]Anthracene by cDNA-Expresed Human Cytochromes P450. Arch. Biochem. Biophys. 1996, 328, 201~207.

>  <DOI>
10.1006/abbi.1996.0161

$$$$
dibenzo_a_l_pyrene
  MOE2008           3D

 24 29  0  0  0  0  0  0  0  0999 V2000
   -1.8990   -1.1580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8310   -2.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6090   -3.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -2.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7680   -3.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9800   -2.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9990   -1.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -0.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750    0.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0900    1.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8300    1.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    1.7450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6200    1.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6880   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5450   -1.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.3940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9830   -3.3580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2430   -2.7730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3520   -1.3910    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1960   -0.6100    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    1.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7320    3.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5070    3.9150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540    3.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 20  2  0  0  0  0
  2  3  1  0  0  0  0
  2 17  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 12 24  2  0  0  0  0
 13 14  1  0  0  0  0
 13 21  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
dibenzo_a_l_pyrene

> <PRIMARY_SOM>
8 17 18

> <SECONDARY_SOM>
5 6 19 20

>  <Citation>
Shou, M.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,l ]pyrene by Human Recombinant Cytochromes P450, Lung and Liver Microsomes. Carcinogenesis 1996, 17, 2429~2433.

>  <DOI>
10.1093/carcin/17.11.2429

$$$$
diclofenac
  MOE2008           3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -1.4770   -0.0940    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4570   -1.0990    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7890   -0.8860    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1740    0.3290    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2210    1.3180    1.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8860    1.1130    0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0780   -2.6480   -0.6420 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7990    2.3680    1.2470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1550   -0.3900   -0.2330 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8020    0.4120   -0.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1410   -0.0110   -0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0970    0.7440   -1.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7320    1.9150   -2.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060    2.3330   -2.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4520    1.5810   -1.5760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5830   -1.2680   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8370   -1.1040    1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2060   -0.0880    1.7840 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6490   -2.2960    1.8370 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  2  7  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  8  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 15  2  0  0  0  0
 11 12  2  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
diclofenac

> <PRIMARY_SOM>
13

>  <Citation>
Bort et al., Biochemical Pharmacology, 58, 787, 1999.

>  <DOI>
10.1016/S0006-2952(99)00167-7

$$$$
diphenhydramine
  MOE2008           3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    1.3570    0.6030   -0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6490    0.9250    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6430    1.6800   -0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2240   -0.2260    0.8720 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4890    0.0400    2.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2200    0.2240    3.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5810   -1.0160    3.4760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1160   -1.7400    2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4010   -0.6540    4.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2150    1.3290   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0060    1.0520   -0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.0480   -1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.6810   -1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610   -0.4050   -1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3960    1.0590   -1.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3110    1.7920   -2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4780    3.1530   -2.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7310    3.7800   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8160    3.0450   -0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  1  0  0  0  0
  1 14  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3 15  1  0  0  0  0
  3 19  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
diphenhydramine

> <PRIMARY_SOM>
8 9

>  <Citation>
Tomoko Akutsu, Kaoru Kobayashi, Koichi Sakurada, Hiroshi Ikegaya, Tomomi Furihata, and Kan Chiba, Identification of Human Cytochrome P450 Isozymes Involved in Diphenhydramine N-Demethylation, DRUG METABOLISM AND DISPOSITION, 35:72~78, 2007

>  <DOI>
10.1124/dmd.106.012088

$$$$
diuron
  MOE2008           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.8090   -2.6710   -0.0070 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4870   -4.5490    0.0090 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.1380    1.7270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970    3.5060   -0.0110 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8440    1.3530   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950   -0.0450   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9820    2.1470   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5340   -0.6380   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9330   -0.8470    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    4.0370   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7780    4.4530   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070   -2.0260   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8110   -2.2340    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -2.8280    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0  0  0  0
  2 14  1  0  0  0  0
  3  7  2  0  0  0  0
  4  7  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
diuron

> <PRIMARY_SOM>
10 11

>  <Citation>
Abass et al.,Drug Metab. Disp.,35,1634,2007

>  <DOI>
10.1124/dmd.107.016295

$$$$
domperidone
  MOE2008           3D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -0.1950    1.4340   -0.2610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0700    0.0850    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8550    2.3930   -0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4820    1.6600   -0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660   -0.5470   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9910   -0.5980    0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220    3.0320   -1.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4990    3.4390    0.9760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1530    0.3960   -0.7970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9400    2.7190   -1.2070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720   -1.8920   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8090   -1.9660    0.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4280    4.0300   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6400    4.4190    1.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4050   -2.5960    0.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0530    5.0410   -0.0920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5730   -4.2810    0.7980 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.2350    5.8540    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9740    7.0210    1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2710    7.7710    1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1230    8.8710    2.1850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7490    8.9400    3.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3340   10.0270    1.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3610   10.1310    4.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6050    8.0520    4.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   10.8220    3.1750 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6590   10.3080    1.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8050   10.5040    5.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0690    8.4110    5.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6750    9.6180    5.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  2  0  0  0  0
  5  9  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
 11 15  2  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 16  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 24  2  0  0  0  0
 22 25  1  0  0  0  0
 23 26  1  0  0  0  0
 23 27  2  0  0  0  0
 24 26  1  0  0  0  0
 24 28  1  0  0  0  0
 25 29  2  0  0  0  0
 28 30  2  0  0  0  0
 29 30  1  0  0  0  0
M  END
>  <ID>
domperidone

> <PRIMARY_SOM>
30

>  <Citation>
Ward et al.,Br. J. Clin. Pharm.,58,277,2004

>  <DOI>
10.111/j.1365-2125.2004.02156.x

$$$$
efavirenz
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
   -1.8520   -4.1700   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6250   -0.2560   -2.3270 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    1.3560   -2.2090 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    1.7930   -1.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.9860    0.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180    3.6190    1.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210    1.5290    1.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.7470    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -0.3270    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5280   -1.7350    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    0.6660   -0.2070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5030   -0.2520    0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9490   -0.2940    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630    0.1600    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    0.1810    0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160    0.8970   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.6530   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030   -0.6710    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1970    2.4430    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570   -2.5080   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1180   -2.0170    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 20  1  0  0  0  0
  2 16  1  0  0  0  0
  3 16  1  0  0  0  0
  4 16  1  0  0  0  0
  5 11  1  0  0  0  0
  5 19  1  0  0  0  0
  6 19  2  0  0  0  0
  7 15  1  0  0  0  0
  7 19  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 11 16  1  0  0  0  0
 12 14  3  0  0  0  0
 13 15  2  0  0  0  0
 13 17  1  0  0  0  0
 15 18  1  0  0  0  0
 17 20  2  0  0  0  0
 18 21  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
efavirenz

> <PRIMARY_SOM>
18

>  <Citation>
Ward et al., J. Pharm. Exp. Ther., 2003, 306, 287-300

>  <DOI>
10.1124/jpet.103.049601

$$$$
endosulfan
  MOE2008           3D

 19 21  0  0  1  0  0  0  0  0999 V2000
   -0.0190    1.5460    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.5220    1.8780   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3130    1.8440    1.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0460    2.3560   -1.2310 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3100   -0.3830    0.6740 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.2520   -0.6290   -1.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8290    0.9580    1.2470 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.8550    3.6200    0.3240 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.3400    1.3000   -1.5020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7470    1.4790    2.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7720    2.5350    2.1320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.0160   -1.4270    1.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1810   -2.0660   -1.0800 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5230    0.9590    1.8650 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8890    1.5740    3.9230 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5340    1.0840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7510   -2.4020    0.2690 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1720   -3.7490    0.1110 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4 11  2  0  0  0  0
  4 12  1  0  0  0  0
  6  8  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 11  1  0  0  0  0
  8 15  1  0  0  0  0
 11 16  1  0  0  0  0
 13 17  1  0  0  0  0
 14 18  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
M  END
>  <ID>
endosulfan

> <PRIMARY_SOM>
18

>  <Citation>
Casabar et al.,Drug Metab. Disp.,34,1779,2006

>  <DOI>
10.1124/dmd.106.010199

$$$$
estradiol
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3770    3.0490   -0.3030 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -2.8320    0.5680 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5030    1.5170    0.0820 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4850    0.0120    0.1280 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2390   -0.7070    0.4930 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.0790   -0.1380   -0.3080 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.8620    1.7620   -0.5710 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.3360    2.0280   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8500   -0.5390   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0140    1.3800   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7010    0.6920    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3070   -2.2050    0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4110    2.0860    1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7840   -0.8400   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0450   -2.8500    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7810   -2.1450    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5660   -0.2330   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5710   -2.8090    0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3590   -0.8960   -0.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -2.1780    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
estradiol

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
19

>  <Citation>
Ohe et al.,Drug Metab. Disp.,28,110,1999
Lee et al.,Endocrinology,144,3382,2003

>  <DOI>
10.1210/en.2003-0192

$$$$
estrone
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3430    2.8640   -0.8390 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420   -2.8500    0.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470    1.6130    0.0460 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4750    0.1110    0.1180 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2310   -0.5980    0.5090 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.1380   -0.1490   -0.4530 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.9000    1.8650   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4060    2.0270   -0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8390   -0.4260   -0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0590    1.3520   -0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7380    0.7270    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3360   -2.1040    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1540    2.2190    1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8350   -0.8490   -0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0420   -2.7180    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8060   -2.0900    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6420   -0.3100   -0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5930   -2.7560    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320   -0.9770   -0.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4230   -2.1930    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  2  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
estrone

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
19

>  <Citation>
Ohe et al.,Drug Metab. Disp.,28,110,1999
Lee et al.,Endocrinology,144,3382,2003

>  <DOI>
10.1210/en.2003-0192

$$$$
ethanol
  MOE2008           3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    2.7320    0.2590   -0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2400    0.2630   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970   -0.0840    1.0520 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
M  END
>  <ID>
ethanol

> <PRIMARY_SOM>
2

>  <Citation>
Hamitouche et al.,Toxic. Let.,167,221,2006

>  <DOI>
10.1016/j.toxlet.2006,09.011

$$$$
etizolam
  MOE2008           3D

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.3060    1.0150    1.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6630    1.9960    2.8980 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0080    1.5430    0.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    2.9930   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3250    0.6940   -0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -0.6840   -0.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0310   -1.2140    0.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2870   -0.3660    1.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2770    3.7010    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720    4.9980    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4770    5.9250    0.8360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8120    5.8700    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1890    4.9250   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1340    3.5340   -0.3090 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510    3.0990   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6200    3.9210    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0640    3.6300   -0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5080    3.8150   -1.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070    5.4300    0.6650 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.4790    7.0590    1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6290    7.5520    2.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7230    7.5960    1.6480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5350    6.8500    0.8380 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  8  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  4  9  1  0  0  0  0
  4 14  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  9 10  2  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 10 19  1  0  0  0  0
 11 12  1  0  0  0  0
 11 20  1  0  0  0  0
 12 13  1  0  0  0  0
 12 23  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 19  1  0  0  0  0
 17 18  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  2  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
etizolam

> <PRIMARY_SOM>
13 21

>  <Citation>
Mandrioli et al.,Curr. Drug Metab.,9,827,2008
Niwa et al.,Biol. Pharm. Bull.,28,1711,2005

$$$$
fenproporex
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    2.2100    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2250    2.1780    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.1500    3.5920    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440    3.5600    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310   -0.1540    2.1120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1690   -2.0450    1.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0560    4.2670    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9420   -0.1080    3.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2130    0.2720    4.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9230    0.3170    5.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    0.3530    6.8710 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  2  0  0  0  0
  5  8  1  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  3  0  0  0  0
M  END
>  <ID>
fenproporex

> <PRIMARY_SOM>
11

>  <Citation>
Kraemer et al.,Biochem Pharm.,68,947,2004

>  <DOI>
10.1016/j.bcp.2004.05.009

$$$$
flunitrazepam
  MOE2008           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.6350   -1.0740    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340   -1.6420   -1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7690   -2.8630   -1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7050   -3.5150   -0.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1100   -2.9490    0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5760   -1.7290    0.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760    0.2440    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9190    1.1410    0.7990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3590    2.4140    1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9290    3.1980    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2820    2.7990   -0.5340 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3990    0.4450    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920    1.6160   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3810    1.6130   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1790    0.5170   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -0.6080    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1990   -0.6590    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -1.7650    0.7750 N   0  3  0  0  0  0  0  0  0  0  0  0
   -2.9600   -1.2200    1.9890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5750    4.1670   -0.3870 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8720    3.6890   -1.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6090   -1.6800    0.6050 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7990   -2.7650    1.2110 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6 19  1  0  0  0  0
  7  8  2  0  0  0  0
  7 12  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 20  2  0  0  0  0
 11 13  1  0  0  0  0
 11 21  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 22  2  0  0  0  0
 18 23  1  0  0  0  0
M  CHG  1  18   1
M  CHG  1  23  -1
M  END
>  <ID>
flunitrazepam

> <PRIMARY_SOM>
21

>  <Citation>
Hesse et al.,Drug Metab. Disp.,29,133,2001

$$$$
fluoxetine
  MOE2008           3D

 22 23  0  0  1  0  0  0  0  0999 V2000
   -0.2060    1.3430    0.2870 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.2290   -0.0220   -0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    1.8010    0.3590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0990    2.3110   -0.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4810   -1.1230    0.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0090   -0.2240   -1.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4980    2.1370    1.6380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470    3.3170   -1.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5000   -2.4100   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0100   -1.5100   -2.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6480    2.0430    2.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    2.6010    1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3240    4.1690   -1.9560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2650   -2.6020   -1.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.4070    4.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2510    2.9650    3.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5900    5.0980   -2.7960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4080    2.8630    4.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8860    3.2740    5.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2270    3.1010    5.7110 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.6440    4.5890    5.8010 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2960    2.5780    6.5510 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7 11  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  2  0  0  0  0
 10 14  1  0  0  0  0
 11 15  1  0  0  0  0
 12 16  2  0  0  0  0
 13 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 19 22  1  0  0  0  0
M  END
>  <ID>
fluoxetine

> <PRIMARY_SOM>
17

>  <Citation>
Mandrioli et al.,Curr. Drug Metab.,7,127,2006

>  <DOI>
10.2174/138920006775541561

$$$$
formononetin
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0180    1.2780    0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    0.0550   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    1.8840    0.7740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360    1.9340    0.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540   -0.6250   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -0.5270   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560    1.2390    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3710    1.3470    0.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410    0.0630   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4780    0.1250    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0810   -1.7050   -1.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5050    1.9850    1.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7690   -0.4620   -0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9390    0.2020   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2000   -0.2870   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3150   -1.4580   -1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1630   -2.1330   -1.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9070   -1.6360   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5870   -1.8650   -1.6370 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5840   -3.0690   -2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 11  2  0  0  0  0
  6 10  2  0  0  0  0
  7  9  2  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 19  1  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
formononetin

> <PRIMARY_SOM>
10

>  <Citation>
Tollesen et al.,J. Agric. Food Chem.,50,4783,2002

>  <DOI>
10.1021/jf025549r

$$$$
halothane
  MOE2008           3D

  7  6  0  0  1  0  0  0  0  0999 V2000
    0.1040   -0.1670    0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570   -0.1470    0.4390 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.7030    1.3300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3010   -1.4020    0.7590 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    0.2250   -0.9860 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1750    0.2560   -1.0660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2770   -1.0090   -2.3420 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
M  END
>  <ID>
halothane

> <PRIMARY_SOM>
5

>  <Citation>
Spracklin et al.,J. Pharma. Exp. Thera.,281,400,1997

$$$$
hexane
  MOE2008           3D

  6  5  0  0  0  0  0  0  0  0999 V2000
   -0.3740   -0.3580   -0.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490    0.0580    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4990   -0.3390    1.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -1.7720    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6410   -2.8150    0.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0590   -2.6050    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
hexane

> <PRIMARY_SOM>
2 5

> <SECONDARY_SOM>
1 3 4 6

>  <Citation>
Crosbie et al., Hum. Exp. Toxicol., 1997, 16, 131-137

>  <DOI>
10.1177/096032719701600301

$$$$
ifosfamide
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -0.0210    1.6800    0.0110 P   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.4930    2.2300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7340    2.1720   -1.1880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8060    2.2240    1.3970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810   -0.4440   -0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7910    3.6920    1.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7710   -0.4020   -1.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3790   -2.1970    0.3810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1550    6.0320    1.6430 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.1790    0.1870   -1.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1130    1.7110   -1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6810   -1.6580    0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1740    4.2310    1.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  8  1  0  0  0  0
  3 12  1  0  0  0  0
  5  7  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 11  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
ifosfamide

> <PRIMARY_SOM>
8

> <SECONDARY_SOM>
7 6

>  <Citation>
Roy et al.,Drug Metab. Disp.,27,655,1999
Roy et al.,Drug Metab. Disp.,27,1309,1999

$$$$
imipramine
  MOE2008           3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.9390    0.1750   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9290    0.2890   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4210    0.0410   -0.6980 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550    0.3590   -0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9520   -1.2380   -0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1160    1.1950   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3050    0.4690    0.4980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2240   -1.6720    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940   -2.0490   -1.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8440    1.3520    0.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480    2.2400   -1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2320   -0.7960    1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6470    0.5320   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -0.7660    1.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7260   -2.9480    0.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7030   -3.3190   -1.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9750    0.3680    1.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5390    2.5500    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7230    3.4200   -1.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9640   -3.7660   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4810    3.5700    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  6 11  1  0  0  0  0
  7 12  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
  8 15  1  0  0  0  0
  9 16  2  0  0  0  0
 10 17  1  0  0  0  0
 10 18  1  0  0  0  0
 11 19  2  0  0  0  0
 14 17  1  0  0  0  0
 15 20  2  0  0  0  0
 16 20  1  0  0  0  0
 18 21  2  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
imipramine

> <PRIMARY_SOM>
12 13

> <SECONDARY_SOM>
20 21

>  <Citation>
E. Koyama, K. Chiba, M. Tani, T. Ishizaki, J. Pharmacol. Exp. Ther. 1997, 281, 1199-1210. 

$$$$
ketamine
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
   -1.4180   -0.8350   -0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7860   -1.0370   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6430    0.0070    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1330    1.2540    0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7650    1.4560    0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9080    0.4130    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3410   -2.1480   -0.6050 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5830    0.6340    0.0900 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2130   -0.2510    1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7220   -0.3410    1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2390   -0.6730   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7030    0.3570   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1780    0.2670   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5280   -0.8690    1.9220 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8690    2.0430    0.3890 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3950    2.8240   -0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  1  0  0  0  0
  8 15  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
ketamine

> <PRIMARY_SOM>
16

>  <Citation>
Hijazi et al.,Drug Metab. Dispos.,30,853,2002

>  <DOI>
10.1124/dmd.30.7.853

$$$$
laam
  MOE2008           3D

 26 27  0  0  1  0  0  0  0  0999 V2000
    0.2730   -0.4230    0.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4890   -1.1960    1.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    0.9770    0.2400 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.7230   -0.3090    0.7780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1650   -1.1540   -0.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9260   -1.4390    0.9960 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.4110    1.7190   -0.7660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2420    1.7100    1.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1370   -0.7450    2.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6400    0.2260   -0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7630   -2.3910   -1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5370   -0.5900   -1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6430   -0.1580    0.9330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6330   -2.3700    1.9840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2090    2.6600   -1.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4670   -0.6400    2.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9700    0.3300    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6640   -3.0610   -2.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6360   -1.2610   -3.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9020   -0.4140    0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    0.1930    2.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3830   -0.0990    1.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0320   -2.4950   -3.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3820    2.8890   -1.3160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9650    3.0540    1.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5580    3.4300   -2.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  2  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  6 14  1  0  0  0  0
  7 15  1  0  0  0  0
  8 25  1  0  0  0  0
  9 16  1  0  0  0  0
 10 17  2  0  0  0  0
 11 18  1  0  0  0  0
 12 19  2  0  0  0  0
 13 20  1  0  0  0  0
 13 21  1  0  0  0  0
 15 24  2  0  0  0  0
 15 26  1  0  0  0  0
 16 22  2  0  0  0  0
 17 22  1  0  0  0  0
 18 23  2  0  0  0  0
 19 23  1  0  0  0  0
M  END
>  <ID>
laam

> <PRIMARY_SOM>
20 21

>  <Citation>
Neff et al.,Biochem. Biophy. Resea. Commun.,284,751,2001

$$$$
lauric_acid
  MOE2008           3D

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.5190    0.5000   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3010    0.4360    0.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7550   -0.6000    1.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4910   -1.9620    1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6330   -2.5340    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9880   -2.4820    0.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0170   -2.9950    2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3490   -4.3360    2.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7500   -5.4150    1.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2410   -5.5800    1.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0230   -5.6260    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0490   -7.0270    3.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8910   -7.8640    2.8570 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0110   -7.2380    3.9890 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
lauric_acid

> <PRIMARY_SOM>
2

>  <Citation>
Imaoka et al.,Biochem. Pharma.,51,1041,1996

>  <DOI>
10.1016/0006-2952(96)00052-4

$$$$
lidocaine
  MOE2008           3D

 17 17  0  0  0  0  0  0  0  0999 V2000
    2.4900    1.1150    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430    1.2950   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3920    0.2360   -0.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890   -1.0080   -0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360   -1.1950   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8840   -0.1340    0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6170   -0.3220    0.9770 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860   -0.1880    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8520   -0.2730    0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8780   -0.0120   -0.1730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1560   -0.4690    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9750    1.4480   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    0.0020   -0.9790 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7830    2.2700    1.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -2.5500   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2120   -1.9980    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0320    1.7920   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 17  1  0  0  0  0
M  END
>  <ID>
lidocaine

> <PRIMARY_SOM>
11 12

>  <Citation>
S. Imaoka et al., Biochemical Pharmacology, 51, 1041-1050,1996

>  <DOI>
10.1016/0006-2952(96)00052-4

$$$$
loperamide
  MOE2008           3D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -0.0870    1.6130    0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1180    0.0720    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3480    2.1340   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9600    2.0840   -1.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6500    2.2080    1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7990   -0.6310   -0.7230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030   -0.6720    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2820    1.9940    0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7680    2.7360   -1.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.7470   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9230    3.5670    1.5170 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8160    1.5110    2.4770 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560   -2.0200   -0.8270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540   -2.0610    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5900    2.4480    0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0760    3.1910   -1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1820    2.2240   -2.0570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4770    4.1110    2.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6820    4.5140    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2210   -2.7350   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9860    3.0470   -0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5420    1.7210   -1.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1570    3.6820   -2.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4440    2.2390   -3.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0320    4.2350   -3.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4690    3.7590   -3.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3700    4.3060   -4.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9520    4.2080   -1.7840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1190    5.5560   -4.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5060    3.5990   -4.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9670    6.0800   -5.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3600    4.1150   -5.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0830    5.3530   -6.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1310    5.9940   -7.2730 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  2  0  0  0  0
  3  9  1  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  2  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8 15  1  0  0  0  0
  9 16  2  0  0  0  0
 10 17  1  0  0  0  0
 11 18  1  0  0  0  0
 11 19  1  0  0  0  0
 13 20  2  0  0  0  0
 14 20  1  0  0  0  0
 15 21  2  0  0  0  0
 16 21  1  0  0  0  0
 17 22  1  0  0  0  0
 17 23  1  0  0  0  0
 22 24  1  0  0  0  0
 23 25  1  0  0  0  0
 24 26  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
 26 28  1  0  0  0  0
 27 29  2  0  0  0  0
 27 30  1  0  0  0  0
 29 31  1  0  0  0  0
 30 32  2  0  0  0  0
 31 33  2  0  0  0  0
 32 33  1  0  0  0  0
 33 34  1  0  0  0  0
M  END
>  <ID>
loperamide

> <PRIMARY_SOM>
19 18

>  <Citation>
Kim et al.,Eur. J. Clin. Pharm.,60,575,2004

>  <DOI>
10.1007/s00228-004-0815-3

$$$$
loratadine
  MOE2008           3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -2.8000    3.7890    0.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2190    4.6740   -0.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1880    4.2350   -1.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    2.9900   -1.1570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    2.0980   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3390    2.4680    0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0290    1.6270    1.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3540    0.3210    1.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090   -0.6610    0.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510   -0.4610   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6980   -1.3510   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5190   -2.4600   -1.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2790   -2.6700   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2290   -1.7750    0.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7760    0.7250   -0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5480    0.5510   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4860    1.7380   -0.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5430    1.5430    0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070    0.1920    0.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2100   -0.9690    0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1440   -0.8380   -0.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4310    0.0200    0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9400   -1.2220    0.1780 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3670   -1.4070   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6790   -2.9020   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1670    0.9850    0.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3030   -4.0670   -0.0950 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  2  0  0  0  0
 10 15  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 13 27  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 21  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 22  1  0  0  0  0
 20 21  1  0  0  0  0
 22 23  1  0  0  0  0
 22 26  2  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
M  END
>  <ID>
loratadine

> <PRIMARY_SOM>
24

>  <Citation>
Ghosal et al.,Drug Metab. Letters,3,162,2009

$$$$
malathion
  MOE2008           3D

 19 18  0  0  1  0  0  0  0  0999 V2000
   -0.0220    1.8100    0.0120 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.4130    2.3390    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7510    2.3090   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0710   -0.4020    0.2020 P   0  0  0  0  0  0  0  0  0  0  0  0
    2.1040    1.9430    1.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0570    2.6100   -1.1340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1600    2.4380   -2.2550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6100    0.2380    1.5770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8640    0.2490   -1.0390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3510   -2.2440    0.2210 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3800    2.3010    1.4920 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    1.3030    2.1150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7600    3.0910   -2.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1460   -0.6050    2.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1230   -0.0750   -2.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0460    1.9190    2.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2240    3.3580   -1.9570 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4820    2.4490    2.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  2  0  0  0  0
  6 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  9 15  1  0  0  0  0
 10 16  1  0  0  0  0
 12 17  1  0  0  0  0
 14 18  1  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
malathion

> <PRIMARY_SOM>
5 11

>  <Citation>
Buratti et al.,Drug Metab. Disp.,33,295,2005

>  <DOI>
10.1124/dmd.104.001693

$$$$
mde
  MOE2008           3D

 15 16  0  0  1  0  0  0  0  0999 V2000
    0.1140    1.1540    0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0540    0.2290   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3460    1.7130    0.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0450    1.4320    0.9270 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9970   -0.1900   -1.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3410   -0.1920   -0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4360    1.3050   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    0.5630    0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2530    0.3620   -1.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8080    1.8600   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1060    2.3590    1.3840 C   0  0  3  0  0  0  0  0  0  0  0  0
    4.3720    1.2300    2.2660 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3190    3.2620    1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4710    1.7100    3.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7430    0.5280    4.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
mde

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
8

>  <Citation>
Kreth et al.,Biochem. Pharm.,59,1563,2000

>  <DOI>
10.1016/S0006-2952(00)00284-7

$$$$
melatonin
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8270   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0840    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -0.7060    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    0.7120   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8920    3.2460    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    1.3690    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950   -0.0240    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9580    3.7610    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6070    2.0270    0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4510    5.1410    1.4430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300    1.0300    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5920    5.8030    2.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0990    7.2220    2.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    5.2570    3.6540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5  7  1  0  0  0  0
  6 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
M  END
>  <ID>
melatonin

> <PRIMARY_SOM>
10

>  <Citation>
X. C. Ma, J. R. Idle, K. W. Krausz, F. J. Gonzalez, Drug Metab. Dispos. 2005, 33, 489-494.

>  <DOI>
10.1124/dmd.104.002410

$$$$
meperidine
  MOE2008           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.1070    0.0550    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2390    1.4800    0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6290   -0.6280   -0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1520   -0.6270    0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3240   -1.9440   -1.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4620   -1.9430    0.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7230   -2.6010   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0520    2.1670   -0.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110    3.6580   -0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420    4.3700   -0.1790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8040    4.3170   -1.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8220    3.7580    0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0540    2.2690    0.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0260    1.4670    1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5370    1.6810    2.9250 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3350    1.1480    1.6040 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0860    1.0670    2.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0450   -0.3560    3.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  8  1  0  0  0  0
  2 13  1  0  0  0  0
  2 14  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  2  0  0  0  0
  5  7  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  2  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
meperidine

> <PRIMARY_SOM>
11

>  <Citation>
Ramirez et al.,Drug Metab. Disp.,32,930,2004

$$$$
mephenytoin
  MOE2008           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
    1.2500    0.9420   -0.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4250    1.8040    0.2060 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.1390    2.5910    1.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920    3.4310    1.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1030    0.8450    0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9730    0.0470    0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9150   -0.6720   -0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2180   -0.5920   -1.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2900    0.2090   -1.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6290    1.0060    0.3460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6220    1.4140   -0.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1290    2.4580   -1.2770 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8670    3.1440   -2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8500    2.7660   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1550    3.6540   -1.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7350    0.9180   -0.6460 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  1  0  0  0  0
  1  9  2  0  0  0  0
  2  3  1  0  0  0  0
  2 10  1  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  2  0  0  0  0
M  END
>  <ID>
mephenytoin

> <PRIMARY_SOM>
13

>  <Citation>
Ko et al.,Drug Metab. Disp.,26,775,1998

$$$$
mephobarbital
  MOE2008           3D

 18 19  0  0  1  0  0  0  0  0999 V2000
    0.7000    0.5720    2.8890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6330    0.4000    1.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490    0.7950    0.2930 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1950    0.5160   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970   -0.6130   -1.0680 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9560    1.5830   -1.0650 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7770    2.9010   -0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6020    3.7260   -1.1460 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6370    3.2110   -0.0370 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910    2.2880    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3820    2.6550    0.8900 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3730    4.6110    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1660   -0.0330   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0070    0.4630   -1.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -0.2840   -1.6760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3390   -1.5520   -1.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5070   -2.0750   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4280   -1.3280    0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 10 11  2  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
mephobarbital

> <PRIMARY_SOM>
12

>  <Citation>
Kobayashi et al., Drug Metab. Disp., 1999, 27, 1429-1433

$$$$
methadone
  MOE2008           3D

 23 24  0  0  1  0  0  0  0  0999 V2000
   -0.2800   -0.2040    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.6930   -1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2220   -1.3680    1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4430    1.0870    0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7690    0.1030   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6390   -1.4750   -1.2290 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5960   -2.7370    0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0300   -1.2160    2.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4940    2.1600   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0610    1.2580    1.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680    0.5580    0.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3660   -0.0610   -1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7430   -0.7930   -0.5850 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9540   -1.9960   -2.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3660   -3.7730    1.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1400    3.3520   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7100    2.4470    2.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9180    0.8410    0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7170    0.2210   -1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7990   -1.7510   -0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3060    0.2320   -1.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7490    3.4940    1.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4920    0.6720   -0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  2  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  6 14  1  0  0  0  0
  7 15  1  0  0  0  0
  9 16  1  0  0  0  0
 10 17  2  0  0  0  0
 11 18  1  0  0  0  0
 12 19  2  0  0  0  0
 13 20  1  0  0  0  0
 13 21  1  0  0  0  0
 16 22  2  0  0  0  0
 17 22  1  0  0  0  0
 18 23  2  0  0  0  0
 19 23  1  0  0  0  0
M  END
>  <ID>
methadone

> <PRIMARY_SOM>
20 21

>  <Citation>
Gerber et at.,Chirality,16,36,2004

>  <DOI>
10.1002/chir.10303

$$$$
methiocarb
  MOE2008           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0250    1.3690    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200   -0.0110   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730    2.0590    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0460    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770   -0.6990   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    1.3730    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270    1.9390    1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -0.0090   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820   -2.1980   -0.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6710    2.1230    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460    2.5130    1.0470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    1.3240    2.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9050   -0.8860   -0.0730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1420    2.3960    2.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2500   -0.8580   -1.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 12  2  0  0  0  0
  8 13  1  0  0  0  0
 11 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
>  <ID>
methiocarb

> <PRIMARY_SOM>
13

>  <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

>  <DOI>
10.1124/dmd.32.3.333

$$$$
methoxychlor
  MOE2008           3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2930    3.0800    2.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
methoxychlor

> <PRIMARY_SOM>
20 21

> <SECONDARY_SOM>
12 13 14 15

>  <Citation>
D. M. Stresser, D. Kupfer, Biochemistry 1997, 36, 2203-2210
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1021/bi962129k
10.1124/dmd.30.9.1035

$$$$
methoxychlor_bis_OH
  MOE2008           3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.1490    1.5290   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2220    0.0790   -0.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4370    2.0770    0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7910    2.4610   -0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7420   -0.3360   -1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2300   -0.8800    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4670    2.5040   -0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6130    2.1460    1.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4240    1.7180   -1.1510 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0290    4.0110   -0.0990 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1760    2.8390   -2.6240 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8050   -1.6900   -2.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1710   -2.2350    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6550    3.0010    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7980    2.6410    2.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3460   -2.6230   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8050    3.0640    1.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4060   -3.9490   -1.5180 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9660    3.5490    1.9260 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
methoxychlor_bis_OH

> <PRIMARY_SOM>
12 13 14 15

>  <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1124/dmd.30.9.1035

$$$$
methoxychlor_mono_OH
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
methoxychlor_mono_OH

> <PRIMARY_SOM>
14 15

> <SECONDARY_SOM>
20

>  <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1124/dmd.30.9.1035

$$$$
metolachlor
  MOE2008           3D

 19 19  0  0  1  0  0  0  0  0999 V2000
   -1.5760   -0.2870    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3410    0.3830   -0.2220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8770   -1.5360   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4970    0.2580    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3080    1.7560   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -0.4640   -0.1750 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.6620   -0.4220   -1.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0840   -2.1800   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0100   -2.1690   -1.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6870   -0.4120    1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2450    1.5110    1.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0770    2.3540   -0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3030    2.4640   -0.6680 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6580   -0.2440    1.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9870   -1.6270    0.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6520   -3.5950   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2880    3.0580   -2.2250 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    0.5260    0.8570 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5060    0.6370    2.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4 10  2  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  5 13  2  0  0  0  0
  6  7  1  0  0  0  0
  6 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 15  1  0  0  0  0
 12 17  1  0  0  0  0
 14 18  1  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
metolachlor

> <PRIMARY_SOM>
19

>  <Citation>
Coleman et al.,Env. Health Perspec.,108,1151,2000
Coleman et al.,Chem. Biol. Inter.,122,27,1999

$$$$
mianserin
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
    3.3030   -1.0630    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2800   -0.2430   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9240    0.9530   -0.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620   -0.7050    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6010    0.4860   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980    1.3170   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9670   -1.6660    0.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3420   -2.0690    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2630   -1.0720    0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4910   -1.3960   -0.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6330   -3.3840    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8610   -3.7090   -0.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7890   -2.7180   -0.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2900    0.9410   -0.3140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8740    0.3610    0.3550 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.4070    2.3720    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8950    3.1080   -0.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9510    2.5710    0.5740 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1500    1.1830    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1830    3.2980    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 15  1  0  0  0  0
 10 13  2  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
mianserin

> <PRIMARY_SOM>
20

> <SECONDARY_SOM>
2

>  <Citation>
Koyama et al.,J. Pharm. Exp. Ther.,278,21,1996

$$$$
midazolam
  MOE2008           3D

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.7560   -3.0120    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6910   -2.0010    0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3430   -0.6950   -0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0330   -0.3960   -0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9040   -1.4390   -0.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5410   -2.7290   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7120   -4.0070   -0.3430 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.4290    0.9650   -0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3420    0.2820   -0.0740 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3780    0.3740    0.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1170    1.3950    0.4520 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6330   -0.5430    1.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5770    1.9920   -0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4640    1.3190   -0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4910    1.6430   -2.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1800    1.8780   -1.4440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7580    1.3320   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8160    1.6010   -1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    1.4040    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0520    1.9430   -0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030    1.7480    1.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2450    2.0190    0.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    1.1390    1.9970 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  2  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8 16  2  0  0  0  0
  8 17  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
 11 13  1  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 17 18  2  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  2  0  0  0  0
 19 23  1  0  0  0  0
 20 22  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
midazolam

> <PRIMARY_SOM>
12

>  <Citation>
S. Ekins et al., J. Pharmacol. Exp. Ther., 1998, 286, 1253-1259

$$$$
montelukast
  MOE2008           3D

 41 45  0  0  1  0  0  0  0  0999 V2000
    1.3780    2.7390    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700    1.4960    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000    2.8890    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6330    3.0390   -1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6360    3.1100    1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2280    4.6290   -1.0920 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4010    2.0600    1.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0000    4.7240   -2.7310 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2090    2.2020    2.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5050    1.0900    0.9370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0100    3.6150   -2.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    6.0750   -2.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8640    2.6770   -3.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0790    3.5360   -2.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    7.1950   -2.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8010    1.6490   -4.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110    2.5210   -2.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3360    8.5170   -3.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6520    0.6430   -5.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8810    1.5800   -3.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0140    9.1550   -2.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2740    9.0930   -4.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -0.3440   -5.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   10.3680   -2.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0770    8.5300   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8950   10.3040   -4.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4060   -1.3480   -6.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5780   10.9410   -3.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660    9.3760    0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5340    8.4640   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5340    7.2100   -0.7850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3770   -1.2660   -7.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3570   -2.3790   -6.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040   -2.1570   -8.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2290   -3.3140   -7.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1320   -3.2150   -8.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -2.0640   -8.9470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9430   -4.1460   -9.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9550   -2.9850   -9.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8710   -4.0240  -10.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000   -2.8630  -11.0170 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  2  0  0  0  0
  8 11  1  0  0  0  0
  8 12  1  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 16 20  2  0  0  0  0
 17 20  1  0  0  0  0
 18 21  2  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 21 24  1  0  0  0  0
 21 25  1  0  0  0  0
 22 26  2  0  0  0  0
 23 27  1  0  0  0  0
 24 28  2  0  0  0  0
 25 29  1  0  0  0  0
 25 30  1  0  0  0  0
 25 31  1  0  0  0  0
 26 28  1  0  0  0  0
 27 32  2  0  0  0  0
 27 33  1  0  0  0  0
 32 34  1  0  0  0  0
 33 35  2  0  0  0  0
 34 36  2  0  0  0  0
 34 37  1  0  0  0  0
 35 36  1  0  0  0  0
 36 38  1  0  0  0  0
 37 39  2  0  0  0  0
 38 40  2  0  0  0  0
 39 40  1  0  0  0  0
 39 41  1  0  0  0  0
M  END
>  <ID>
montelukast

> <PRIMARY_SOM>
6

>  <Citation>
Chiba et al.,Drug Metab. Dispos.,25,1022,1997

$$$$
nabumetone
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1850    1.3840   -0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1530   -0.0250   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9950    2.0910   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950    2.0560    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330   -0.7320    0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0580   -0.6960   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    1.4170   -0.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680    1.3390    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5420   -0.0540    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2300    0.0220   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4360    2.2240   -0.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6420   -0.8360    0.5450 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370    1.5970   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170   -0.0470    0.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8810    1.5910    1.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5260    2.8500    1.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360    0.6150    1.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
M  END
>  <ID>
nabumetone

> <PRIMARY_SOM>
16

>  <Citation>
Turpeinen et al.,Drug Metab. Disp.,37,1017,2009

>  <DOI>
10.1124/dmd.108.025700

$$$$
nevirapine
  MOE2008           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
    1.2930    0.0880    0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3760    0.9760   -0.2790 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1310   -1.2910    0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0110   -2.1770    0.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0260   -1.6530    1.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1440   -0.2810    1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2950    0.5370    0.9970 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.8050   -0.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8120    2.0200   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -1.3290   -0.9540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6970   -0.2800   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9680    0.8660    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5420    1.8740    0.7210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7950    1.8180    1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5650    0.6950    0.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0140   -0.3760    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3790   -2.7510   -1.5530 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8430    3.0310   -0.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8270   -1.6160   -0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2550    1.9580   -1.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  2  0  0  0  0
  2  9  1  0  0  0  0
  2 12  1  0  0  0  0
  3  4  2  0  0  0  0
  3  8  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8 10  1  0  0  0  0
  8 17  2  0  0  0  0
  9 18  1  0  0  0  0
  9 20  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  2  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
nevirapine

> <PRIMARY_SOM>
15

> <SECONDARY_SOM>
5

>  <Citation>
Erickson et al.,Drug Metab. Disp.,27,1488,1999

$$$$
nicardipine
  MOE2008           3D

 35 37  0  0  1  0  0  0  0  0999 V2000
    0.4840    1.2560   -0.4290 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0690   -0.1930   -0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    1.4680   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    1.9000   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7920   -0.5650    0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5350   -1.1680   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140    1.9570   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5500    1.1140    1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    2.3970   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410    1.9810   -1.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1640   -1.9000    0.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510   -2.5010   -1.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    2.3860   -2.4610 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000    2.1000   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5450    1.9680    1.4020 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    0.2070    1.7610 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840    3.0490   -3.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880    1.7490   -3.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2430    2.1700   -0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7020   -2.8750   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0500   -2.2870    1.9280 N   0  3  0  0  0  0  0  0  0  0  0  0
    4.1550    1.6340    2.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4110    1.7770   -3.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6020   -1.3850    2.5740 O   0  5  0  0  0  0  0  0  0  0  0  0
   -2.2120   -3.4990    2.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1330    0.4760    2.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2770    0.7730    1.6420 N   0  0  3  0  0  0  0  0  0  0  0  0
    7.0530    1.8480    2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1050   -0.4220    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9580    2.5380    1.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4510    3.5100    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3160    2.2210    1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2960    4.1560   -0.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1610    2.8670    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6500    3.8340   -0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 13  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 10 19  2  0  0  0  0
 11 20  2  0  0  0  0
 11 21  1  0  0  0  0
 12 20  1  0  0  0  0
 15 22  1  0  0  0  0
 18 23  1  0  0  0  0
 21 24  1  0  0  0  0
 21 25  2  0  0  0  0
 22 26  1  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
 27 29  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  2  0  0  0  0
 30 32  1  0  0  0  0
 31 33  1  0  0  0  0
 32 34  2  0  0  0  0
 33 35  2  0  0  0  0
 34 35  1  0  0  0  0
M  CHG  1  21   1
M  CHG  1  24  -1
M  END
>  <ID>
nicardipine

> <PRIMARY_SOM>
28

>  <Citation>
Nakamura et al.,Biol. Pharm. Bull.,28,882,2005

>  <DOI>
10.1248/bpb.28.882

$$$$
nicotine
  MOE2008           3D

 12 13  0  0  1  0  0  0  0  0999 V2000
    1.1240    0.6150   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1580    1.2470    0.6500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0140    0.5900    0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5920   -1.2980    0.4680 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2680   -0.6650    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2420   -1.2800   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -0.6390   -0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7190   -0.9130   -0.3960 N   0  0  3  0  0  0  0  0  0  0  0  0
   -3.2950   -0.5140   -1.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5110   -2.1420   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1360   -2.9830    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   -2.8070    0.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 12  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
nicotine

> <PRIMARY_SOM>
9

> <SECONDARY_SOM>
10

>  <Citation>
Yamazaki et al.,Arch. Toxicol.,73,65,1999
Yamanaka et al.,Drug Metab. Disp.,33,1811,2005

>  <DOI>
10.1007/s002040050588
10.1124/dmd.105.006254

$$$$
nor_laam
  MOE2008           3D

 25 26  0  0  1  0  0  0  0  0999 V2000
    0.3130   -0.3560    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5060   -1.1500    1.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2100    1.1070    0.2640 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.7790   -0.3270    0.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1700   -1.1270   -0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9610   -1.4530    1.0650 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.4570    1.9220   -0.7010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2430    1.7780    1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500   -0.7530    2.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7890    0.1420   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350   -2.4050   -1.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5580   -0.6180   -2.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8140   -0.2880    0.9250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4980   -2.4320    2.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3990    2.6260   -1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4790   -0.7170    2.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1200    0.1800    0.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5950   -3.1360   -2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7030   -1.3430   -3.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1020    0.3230    2.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4640   -0.2500    1.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1240   -2.6030   -3.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6190    2.6180   -1.4160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3710    3.2800    1.5970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3800    3.4310   -2.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  2  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  6 14  1  0  0  0  0
  7 15  1  0  0  0  0
  8 24  1  0  0  0  0
  9 16  1  0  0  0  0
 10 17  2  0  0  0  0
 11 18  1  0  0  0  0
 12 19  2  0  0  0  0
 13 20  1  0  0  0  0
 15 23  2  0  0  0  0
 15 25  1  0  0  0  0
 16 21  2  0  0  0  0
 17 21  1  0  0  0  0
 18 22  2  0  0  0  0
 19 22  1  0  0  0  0
M  END
>  <ID>
nor_laam

> <PRIMARY_SOM>
20

>  <Citation>
Neff et al.,Biochem. Biophy. Resea. Commun.,284,751,2001

$$$$
o-phenylphenol
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.9830    2.1830    0.7750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520   -0.1310    0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250   -0.1760    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5380    0.9910    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560   -1.2880   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010    0.9030    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190   -1.3300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9330    0.9640    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8480   -1.3320   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8950    0.8450    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -1.4060   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5890   -0.2000   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -0.3140    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  2  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  2  0  0  0  0
  8 12  2  0  0  0  0
  9 12  1  0  0  0  0
 10 13  2  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
o-phenylphenol

> <PRIMARY_SOM>
9

>  <Citation>
Ozawa et al.,Xenobiotica,30,1005,2000

>  <DOI>
10.1080/00498250050200159

$$$$
oxycodone
  MOE2008           3D

 23 27  0  0  1  0  0  0  0  0999 V2000
   -0.2940    1.5470   -0.1680 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5160    0.0620   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.7270   -0.0160 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.1640    1.8480    1.0420 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7710    2.2670   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920   -0.2610    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.8350   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8700    1.1380   -1.2620 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.7020    1.0060    1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5160    3.1200    0.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070    0.8330    0.9350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4410    1.6050    2.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0070    1.6840   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1160   -1.5940    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.3550   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940   -2.1490   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4340    1.8770   -2.4490 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.0510    1.6530    2.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    1.3580    3.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2960   -2.5020   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2750   -1.9870    0.8920 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0870    1.2470   -3.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980   -3.3930    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4 11  1  0  0  0  0
  4 12  1  0  0  0  0
  5 13  1  0  0  0  0
  6 11  1  0  0  0  0
  6 14  1  0  0  0  0
  7 15  1  0  0  0  0
  7 16  2  0  0  0  0
  8 15  1  0  0  0  0
  8 17  1  0  0  0  0
  9 18  1  0  0  0  0
 12 18  1  0  0  0  0
 12 19  2  0  0  0  0
 13 17  1  0  0  0  0
 14 20  2  0  0  0  0
 14 21  1  0  0  0  0
 16 20  1  0  0  0  0
 17 22  1  0  0  0  0
 21 23  1  0  0  0  0
M  END
>  <ID>
oxycodone

> <PRIMARY_SOM>
22

>  <Citation>
Lalovic et al.,Drug Metab. Disp.,32,447,2004

>  <DOI>
10.1124/dmd.32.4.447

$$$$
parathion
  MOE2008           3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.9290    0.1620 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050    0.5790    0.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5230    1.4100   -0.3740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    2.1230   -1.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1080    3.4820    1.3270 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1520   -0.1220    1.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210    0.2970   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2870    3.1600   -2.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9370   -1.1930    2.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0330    0.1850    2.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9540   -0.0440   -1.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    3.1510   -3.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5440   -1.9580    3.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.5730    3.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6400   -1.6380    4.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0550   -2.4310    5.1580 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.3190   -3.3640    5.5080 O   0  5  0  0  0  0  0  0  0  0  0  0
    2.1190   -2.1260    5.7130 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  2  0  0  0  0
 13 15  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  2  0  0  0  0
M  CHG  1  16   1
M  CHG  1  17  -1
M  END
>  <ID>
parathion

> <PRIMARY_SOM>
1 5

>  <Citation>
Mutch et al.,Toxicology,224,22,2006

>  <DOI>
10.1016/j.tox.2006.04.024

$$$$
perazine
  MOE2008           3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3900    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    2.1590    0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0000   -0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    2.0730    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3540    1.7290   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680    3.3850    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -0.6710   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960   -0.7200    0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8160    2.1910    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5050    0.1890   -1.2380 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4820    2.5340   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1940    4.1760    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0610   -2.0600   -0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1140   -2.0990    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1700    2.9040    1.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4010    3.7500    0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0350   -2.7680   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530    3.0180    2.8520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170    3.9120    2.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1460    1.6890    3.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4500    3.9810    4.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7790    1.7590    4.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9440    2.6530    4.5960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4270    2.7670    5.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
perazine

> <PRIMARY_SOM>
10

> <SECONDARY_SOM>
24

>  <Citation>
Wojcikowski et al.,Europ. Neuropsychopharm.,14,199,2004

>  <DOI>
10.1016/S0924-977X(03)00105-6

$$$$
perhexiline
  MOE2008           3D

 20 22  0  0  1  0  0  0  0  0999 V2000
    8.1390   -1.6600    0.6620 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6470   -0.4700   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3410   -1.1850    0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6300    1.0160    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8020   -1.1750    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1370   -0.5670   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4310   -2.6690   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8840    1.8230   -0.9710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2340    1.3220    1.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1920   -0.7830   -0.0090 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.8420   -1.2710   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1630   -3.4200    0.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8570    3.3010   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2120    2.7960    1.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8980   -2.7740   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5510    3.6600    0.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5110    0.6790    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9290    1.0350   -0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4850   -1.4000    0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9180    0.0350    0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0  0  0  0
  1 19  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  1  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  1  0  0  0  0
 10 17  1  0  0  0  0
 11 15  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 20  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
perhexiline

> <PRIMARY_SOM>
15 16

>  <Citation>
Davies et al.,Drug Metab. Disp.,35,128,2007

>  <DOI>
10.1124/dmd.106.012252

$$$$
phenanthrene
  MOE2008           2D

 14 16  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    3.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  1  0  0  0  0
  2 11  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
phenanthrene

> <PRIMARY_SOM>
4 5

> <SECONDARY_SOM>
7 8 13 14

> <TERTIARY_SOM>
9 10 11 12

>  <Citation>
Shou et al., Canc. Lett. 1994, 83, 305-313

>  <DOI>
10.1016/0304-3835(94)90334-4

$$$$
phorate
  MOE2008           3D

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0600    1.8750   -0.0690 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2770   -0.1900   -0.4090 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6440    2.1570   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5900    2.7300   -1.2680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240    2.3750    1.5460 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.4140   -0.3510   -2.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1000    1.6730    1.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0060    2.6970   -1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2260   -0.3430   -1.9850 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6060    1.9120    1.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6950    3.3750   -2.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5160   -2.0150   -1.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0200   -2.2440   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
phorate

> <PRIMARY_SOM>
9

>  <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

>  <DOI>
10.1124/dmd.32.3.333

$$$$
promazine
  MOE2008           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0430    1.5840    0.0510 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    2.4400    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690    0.1900   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720    2.2060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    1.9520    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9770    3.8260    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2760   -0.5260   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1230   -0.5360   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7560    2.2410    1.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8770    0.2290   -0.0190 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500    2.8320    0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0540    4.7000    0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -1.9130   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1310   -1.9160   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1070    2.9140    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3470    4.2000    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700   -2.6070   -0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6150    2.9690    2.9600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940    3.8840    3.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9430    3.5530    2.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
promazine

> <PRIMARY_SOM>
20 19

> <SECONDARY_SOM>
10

>  <Citation>
Wojcikowski et al.,Br. J. Pharm.,138,1465,2003

>  <DOI>
10.1038/sj.bjp.0705195

$$$$
propofol
  MOE2008           3D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.2200    0.7140    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.4740    0.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    1.1810    1.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4290    1.1690   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020    2.7620    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    0.7100   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4950    1.4650   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1880    1.1570   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4210    1.1700    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930   -0.6880   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.3830    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6840    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  1  0  0  0  0
  1 13  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
propofol

> <PRIMARY_SOM>
12

>  <Citation>
Court et al.,Anesthesiology,94,110,2001
J. Guitton, T. Buronfosse, M. Desage, J. P. Flinois, J. P. Perdrix, J. L. Brazier, P. Beaune, Br. J. Anaesth. 1998, 80, 788-795.

$$$$
quinoline
  MOE2008           3D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0210    0.6400   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.7540   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    1.3900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470    1.3740    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -1.4600   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090   -1.4360   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.6780   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440    0.6720   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440   -0.7300    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3580   -0.7260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
quinoline

> <PRIMARY_SOM>
4 8

>  <Citation>
Reigh et al., Carcinogenesis, 1996, 17, 1989-1996

$$$$
rabeprazole_thioether
  MOE2008           3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.0830    1.2680    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -0.0140   -0.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1930    1.7400    0.1980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4260    2.3220    0.3360 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1100    1.6960    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7460    1.0830    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7120    1.9050   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -0.3900   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0430    0.6940   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7080    2.0160    1.3870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9840    2.4790   -1.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9380    2.5700    1.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6120    2.8200    0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5470    2.6750   -2.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3580    3.4700   -3.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0170    1.5260   -2.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7590   -1.6470   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1890    4.2790   -4.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4350    0.6110   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8340    3.2750   -2.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7230    4.1080   -3.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4720    4.8780   -4.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680   -0.6510   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1520   -1.7570   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  6  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  5 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  2  0  0  0  0
  8 17  1  0  0  0  0
  9 19  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 20  1  0  0  0  0
 15 20  1  0  0  0  0
 15 21  1  0  0  0  0
 17 24  2  0  0  0  0
 18 21  1  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
rabeprazole_thioether

> <PRIMARY_SOM>
22

>  <Citation>
Miura et al.,Eur. J. Clin. Pharmacol.,62,113,2006

>  <DOI>
10.1007/s00228-005-0077-8

$$$$
ropivacaine
  MOE2008           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
    0.9280   -0.5320    0.8250 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2230   -0.2590    0.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870    0.7210    0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2640    0.9880    0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    0.2810   -0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0250   -0.6950   -1.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7490   -0.9710   -0.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4220    1.4920    2.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9260   -2.0400   -1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1230   -0.3870   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5170   -0.6870    0.4830 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0530   -0.0150   -1.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    0.1390   -0.2530 N   0  0  3  0  0  0  0  0  0  0  0  0
   -1.8270   -2.1680    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2310   -2.4750    0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7980   -0.0850    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2340   -1.5320    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    1.5400    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8200    2.4450   -1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4510    3.9040   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  2  0  0  0  0
  3  4  2  0  0  0  0
  3  8  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  9  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 13 16  1  0  0  0  0
 13 18  1  0  0  0  0
 14 15  1  0  0  0  0
 15 17  1  0  0  0  0
 16 17  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
ropivacaine

> <PRIMARY_SOM>
5

>  <Citation>
Oda et al.,Anesthes.,82,214,1995

$$$$
selegiline
  MOE2008           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
    3.7100    1.4800    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9440    0.2810   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9200   -0.6550   -0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.4050   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4320    0.8000    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.7400    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -1.4520   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7660   -1.2830    0.2630 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5700   -0.1870   -0.2590 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.6710   -1.2840    1.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7140   -0.3550   -1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6520    0.9880    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2720    2.0080    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9040   -0.2580    0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 12 13  3  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
selegiline

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
11

>  <Citation>
Benetton et al., Drug Metab. Pharma.,2,78,2007

>  <DOI>
10.2133/dmpk.22.78

$$$$
seratrodast
  MOE2008           3D

 26 27  0  0  1  0  0  0  0  0999 V2000
   -0.5280   -0.2200   -0.7970 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.3570   -1.6160   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0140   -1.8050    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1710   -3.0850    1.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420   -4.1770    0.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4140   -3.9880   -0.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5770   -2.7080   -1.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9030    0.2890   -0.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5280    0.6990   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7990    0.5180   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2640    0.5310    0.9640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1460    1.0180   -1.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4540    0.3190    1.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6120    1.0300    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9580    1.2250   -1.9540 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5060    1.2650    0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8800    1.7750    0.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9800    1.2770    2.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    0.2660   -2.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9240    0.1820   -0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9800    1.1010    0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3760    0.5840   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4320    1.5030    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8070    0.9940   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8960    1.6470    0.4290 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9290   -0.0030   -0.6800 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 20  1  0  0  0  0
 10 12  1  0  0  0  0
 10 19  1  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 15  2  0  0  0  0
 12 16  1  0  0  0  0
 14 16  2  0  0  0  0
 14 18  1  0  0  0  0
 16 17  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 24 26  2  0  0  0  0
M  END
>  <ID>
seratrodast

> <PRIMARY_SOM>
17

>  <Citation>
Kumar et al.,Drug Metab. Disp.,25,110,1997

$$$$
sertraline
  MOE2008           3D

 20 22  0  0  1  0  0  0  0  0999 V2000
   -2.6400    8.7890    2.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3890    7.7420    1.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3700    8.5450    3.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8700    6.4500    1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6020    6.1870    2.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8450    7.2490    3.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    4.7890    2.4670 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.5370    7.0210    3.5880 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2020    5.9260    2.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4210    4.6270    2.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8650    3.7630    3.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5970    2.8260    2.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650    1.8690    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9120    3.7320    4.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6790    2.7760    5.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4080    1.8420    4.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5260    6.6110    4.9900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3830    0.6260    5.2570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.6750    2.8170    6.9810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2510    7.7690    5.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 17  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 13 16  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 18  1  0  0  0  0
 17 20  1  0  0  0  0
M  END
>  <ID>
sertraline

> <PRIMARY_SOM>
20

>  <Citation>
Obach et al.,Drug Metab. Disp.,33,262,2005

>  <DOI>
10.1124/dmd.104.002428

$$$$
sibutramine
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
    5.9900   -4.5060    0.7070 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.5330    3.3040    0.8270 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0530    1.5120   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3050    2.0940   -1.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2200    2.4020    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    1.8860    0.5440 C   0  0  3  0  0  0  0  0  0  0  0  0
    6.6230    2.7000   -0.9690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3030   -0.0540    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5760    1.1530   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2240    1.0640    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5990   -0.6080    1.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2330   -0.9560   -0.9250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9520    4.0300   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6980    3.4890    1.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4550   -0.0700   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4110    2.3220    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8120   -1.9740    1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4430   -2.3250   -0.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7320   -2.8240    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 19  1  0  0  0  0
  2  6  1  0  0  0  0
  2 13  1  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  3  8  1  0  0  0  0
  4  7  1  0  0  0  0
  5  7  1  0  0  0  0
  6  9  1  0  0  0  0
  8 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 15  1  0  0  0  0
 10 16  1  0  0  0  0
 11 17  1  0  0  0  0
 12 18  2  0  0  0  0
 17 19  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
sibutramine

> <PRIMARY_SOM>
13 14

>  <Citation>
Bae et al.,Drug Metab. Disp.,36,1679,2008

>  <DOI>
10.1124/dmd.108.020727

$$$$
styrene
  MOE2008           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.1560    0.6760   -0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180    1.4440   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500    2.8720   -0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550    3.5830   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1130    0.8270    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.5390    0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0300   -1.2970    0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1630   -0.6900   -0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  2  0  0  0  0
  3  4  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
styrene

> <PRIMARY_SOM>
3 4

>  <Citation>
Nakajima et al.,Chem. Res. Toxicol.,7,891,1994

>  <DOI>
10.1021/tx00042a026

$$$$
sulfadiazine
  MOE2008           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0220    1.7580    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    2.4640    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.4310    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240   -0.5080    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2600   -0.4040   -0.5140 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650   -0.3700   -0.5380 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.8450    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520    3.8120    0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0580   -0.2500    2.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    4.5240    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1660   -0.9020    3.5510 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    0.6460    2.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0780    5.9210    0.0360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1880   -0.6800    4.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    0.9160    2.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1520    0.2480    3.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  8 11  2  0  0  0  0
  9 11  1  0  0  0  0
 10 12  2  0  0  0  0
 10 13  1  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  2  0  0  0  0
 15 17  2  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
sulfadiazine

> <PRIMARY_SOM>
14

>  <Citation>
Winter and Unadkat,Drug Metab. Disp.,33,969,2005

>  <DOI>
10.1124/dmd.104.002998

$$$$
tamoxifen
  MOE2008           3D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -0.0590    1.3520   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0030    0.0160    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1860    2.1280   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3710    2.0320   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.6820    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520   -0.7520    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4490    2.7380   -1.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0980    2.2570    0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7380    2.9370    0.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2460    1.7760   -1.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8400   -1.2710    1.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9820   -0.7670   -1.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100   -0.8560    1.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6100    3.4600   -1.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2570    2.9810    0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9630    3.5680    0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4680    2.4140   -1.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0520   -1.9240    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930   -1.4250   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5180    3.5820   -0.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8280    3.3050   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7290   -1.9990   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6610    4.2940   -0.8300 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3780    4.2360    0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6840    5.0230    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3790    6.4450    0.0670 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9790    6.9850    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6450    7.1000   -0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  2  0  0  0  0
  5 12  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
  9 16  1  0  0  0  0
 10 17  2  0  0  0  0
 11 18  1  0  0  0  0
 12 19  2  0  0  0  0
 14 20  2  0  0  0  0
 15 20  1  0  0  0  0
 16 21  2  0  0  0  0
 17 21  1  0  0  0  0
 18 22  2  0  0  0  0
 19 22  1  0  0  0  0
 20 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  1  0  0  0  0
 26 28  1  0  0  0  0
M  END
>  <ID>
tamoxifen

> <PRIMARY_SOM>
21

> <SECONDARY_SOM>
22

>  <Citation>
Crewe et al., Drug Metab. Dispos. 2002, 30, 869-874

>  <DOI>
10.1124/dmd.30.8.869

$$$$
tegafur
  MOE2008           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
    6.6960   -0.3830    0.8750 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -0.4070    2.4460 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1800   -4.3660    1.8820 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4870   -2.9820    0.9680 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -2.0840    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3240   -3.6770    1.4260 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2240   -1.6940    1.8100 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4360   -1.5700    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4310   -0.5020    0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530    0.4220    1.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9590   -3.4380    1.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5070   -1.0880    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7950   -1.3500    1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3030   -2.7300    1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  2  7  1  0  0  0  0
  2 10  1  0  0  0  0
  3 11  2  0  0  0  0
  4 14  2  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 11  1  0  0  0  0
  6 14  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
tegafur

> <PRIMARY_SOM>
7

>  <Citation>
Komatsu, T.; Yamazaki, H.; Shimada, N.; Nakajima, M.; Yokoi, T. Roles of Cytochromes P450 1A2 2A6, and 2C8 in 5-Fluorouracil Formation from Tegafur, an Anticancer Prodrug, in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 1457~1463. 

$$$$
temazepam
  MOE2008           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    1.6630   -2.6700    0.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3140   -1.4670    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7300   -0.2280    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4280   -0.2230   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190   -1.4360   -0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4020   -2.6470   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4120   -4.1160   -0.6280 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3740    1.0220   -0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000    0.9360    0.4770 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5320    0.8610    1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9860    3.1640    0.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    2.1510   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4820    2.0860   -1.4310 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.8650    3.0470   -2.3900 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0920    2.1140   -1.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8020    1.0430   -0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2560    0.2150    0.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6800    1.9440   -0.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5870    0.2750    1.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110    2.0020   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4630    1.1660    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  2  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8 15  2  0  0  0  0
  8 16  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 16 17  2  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  2  0  0  0  0
 19 21  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
temazepam

> <PRIMARY_SOM>
10

>  <Citation>
Yang et al.,Biochem. Pharmacol.,55,889,1998

$$$$
terbinafine
  MOE2008           3D

 22 23  0  0  1  0  0  0  0  0999 V2000
   -6.4320    0.3690    0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6890    1.4420    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3470    1.2600   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7860   -0.0420   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840   -1.1250    0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8790   -0.9090    0.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5480    2.3420   -0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2520    2.1280   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7010    0.8480   -0.7810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4430   -0.2240   -0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8280   -1.6000   -0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3890   -1.4990   -0.6380 N   0  0  3  0  0  0  0  0  0  0  0  0
    0.0720   -2.8540   -0.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2590   -1.1310    0.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7460   -1.0100    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3600    0.1440    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7730    0.2590    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9310    0.3530    0.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3840    0.4700    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8350    1.8920    0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1110   -0.5270    0.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7150    0.1680   -1.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  2  0  0  0  0
  4  5  1  0  0  0  0
  4 10  2  0  0  0  0
  5  6  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  3  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  1  0  0  0  0
 19 22  1  0  0  0  0
M  END
>  <ID>
terbinafine

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
1 2 7 8 11 20 21 22

>  <Citation>
Vickers et al.,Drug Metab. Disp.,27,1029,1999

$$$$
terbutryne
  MOE2008           3D

 16 16  0  0  0  0  0  0  0  0999 V2000
   -0.1960   -1.5640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9010   -0.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000    0.5120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3990    1.0880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4970    0.3370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950   -0.9880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5340   -1.7680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8550   -1.1340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9390   -2.2140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1450   -1.4110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550   -0.5840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3690    0.3000    1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5900   -1.4870    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5330    2.8450    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3690    0.2990   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3340    3.0220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  2 10  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 15  1  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <ID>
terbutryne

> <PRIMARY_SOM>
14

> <SECONDARY_SOM>
8

>  <Citation>
Lang et al.,Chem. Res. Toxicol,10,1037,1997

$$$$
testosterone
  MOE2008           3D

 21 24  0  0  1  0  0  0  0  0999 V2000
   -3.5280    1.3340   -0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3400    0.1210   -0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5710   -1.0820   -0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200   -0.9440    0.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6470    0.3790    0.4750 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.4960    1.5930    0.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5130   -2.1920    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1990   -2.1070   -0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5230   -0.8000    0.1460 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.3310    0.3990   -0.3040 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.8450   -0.7340   -0.5950 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.5640    0.5620   -0.1340 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.7910    1.7330   -0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3880    1.7220   -0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.8200   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2170   -1.1780   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9910    0.3710   -0.6380 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2740    0.4660    1.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5600    0.6420    1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9180    1.0060    0.2450 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5530    0.1410   -0.4630 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  2  3  1  0  0  0  0
  2 21  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  5 10  1  0  0  0  0
  5 18  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 11 15  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  1  0  0  0  0
 12 19  1  0  0  0  0
 13 14  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 20  1  0  0  0  0
M  END
>  <ID>
testosterone

> <PRIMARY_SOM>
16

>  <Citation>
Imaoka et al.,Biochem. Pharma.,51,1041,1996

>  <DOI>
10.1016/0006-2952(96)00052-4

$$$$
thalidomide
  MOE2008           3D

 19 21  0  0  1  0  0  0  0  0999 V2000
   -3.3840    3.5470   -0.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6730    4.1890   -2.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6380    4.6850   -3.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3770    5.6330   -3.9220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170    3.9850   -3.3150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2860    2.9320   -2.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3080    2.3310   -2.8870 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4440    2.5220   -1.3570 C   0  0  3  0  0  0  0  0  0  0  0  0
   -3.9530    1.1600   -1.5430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1300    0.7390   -2.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6770    1.3650   -3.4950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8950   -0.6870   -2.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1420   -1.5910   -3.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1140   -2.9120   -2.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8290   -3.2910   -1.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5850   -2.3560   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5970   -1.0600   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2750    0.1270   -0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9640    0.1360    0.3080 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 18  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
M  END
>  <ID>
thalidomide

> <PRIMARY_SOM>
2

>  <Citation>
Ando et al., Clin. Cancer Res., 2002 8, 1964-1973

$$$$
theophylline
  MOE2008           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
    1.2130    0.5920    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370    1.3820    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0200    2.5990    0.2840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    0.6030   -0.1330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    1.3030   -0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1340   -0.7960   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1870   -1.3920   -0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0870   -1.4650   -0.1920 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1180   -2.8950   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.7620    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890   -1.2730    0.2160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2420   -0.2170    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5020    0.9400    0.4830 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
theophylline

> <PRIMARY_SOM>
12

>  <Citation>
Zhang and Kaminsky,Biochem. Pharmacol.,50,205,1995

>  <DOI>
10.1016/0006-2952(95)00120-O

$$$$
thioridazine
  MOE2008           3D

 25 28  0  0  1  0  0  0  0  0999 V2000
   -0.9640    0.8750    0.5140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.4900    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -0.9560    1.9930 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2420    1.4560    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -1.4430    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    0.7390    1.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1130    1.7600    0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    3.5460   -2.7700 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1700   -0.9020   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.2420   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120    3.1940   -1.3480 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5680   -2.7940    0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -2.2540   -0.7700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6850   -2.7690   -1.8460 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5840   -3.2010   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4880    2.3410   -3.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5630    4.4280   -3.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4720    2.7920    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    1.3590    1.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930    4.4630   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.5780   -1.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3800    5.7340   -2.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560    3.4020    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6200    2.6890    1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2650    5.4220   -0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  7  1  0  0  0  0
  2  5  2  0  0  0  0
  2  9  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  6  2  0  0  0  0
  4 18  1  0  0  0  0
  5 12  1  0  0  0  0
  6 19  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  8 16  1  0  0  0  0
  8 17  1  0  0  0  0
  9 13  2  0  0  0  0
 10 11  1  0  0  0  0
 11 20  1  0  0  0  0
 12 15  2  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 14 21  1  0  0  0  0
 17 22  1  0  0  0  0
 18 23  2  0  0  0  0
 19 24  2  0  0  0  0
 20 25  1  0  0  0  0
 22 25  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
thioridazine

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
14

>  <Citation>
Wojcikowski et al.,Drug Metab. Disp.,34,471,2006

>  <DOI>
10.1124/dmd.105.006445

$$$$
tolperisone
  MOE2008           3D

 18 19  0  0  1  0  0  0  0  0999 V2000
   -0.0460    1.4750    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0040    0.0040   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1400    2.2130   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2730    2.1410    0.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850   -0.7880    0.0410 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.0620   -0.5710   -0.0870 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0930    3.5910   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3040    3.5190    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680   -2.1560   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7040   -0.9770    1.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1260    4.2430    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3300   -2.9080   -0.6010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1690    5.7490    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0760   -4.1650   -1.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2850   -2.1370   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3540   -5.0050   -1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300   -2.8640   -1.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4400   -4.2340   -2.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 10  1  0  0  0  0
  7 11  2  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
tolperisone

> <PRIMARY_SOM>
13

>  <Citation>
Dalmadi et al.,Drug Metab. Disp.,31,631,2003

>  <DOI>
10.1124/dmd.31.5.631

$$$$
toluene
  MOE2008           3D

  7  7  0  0  0  0  0  0  0  0999 V2000
    1.2070    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.3980   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8860   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.3880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  2  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
toluene

> <PRIMARY_SOM>
3

> <SECONDARY_SOM>
6

>  <Citation>
Tamie Nakajima , Rui-Sheng Wang, Eivor Elovaara, Frank J. Gonzalez, Harry V. Gelboin, Hannu Raunio, Olavi Pelkonen, Harri Vainio and Toshifumi Aoyama. Toluene Metabolism by cDNA-Expressed Human Hepatic Cytochrome P450, Biochemical Pharmacology, Vol. 53, pp. 271-277, 1997

>  <DOI>
10.1016/S0006-2952(96)00652-1 

$$$$
tramadol
  MOE2008           3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -1.9880   -1.1680    1.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1420   -0.8650    0.8520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1050    0.0640   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9090    0.6850   -0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7580    0.3790    0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7990   -0.5430    1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2380    0.3630   -0.8660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2850   -0.4290   -0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5420    1.0540   -0.1620 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6910    2.3380    0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0100    3.0230    0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750    2.0820    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0260    0.7980   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7070    0.1130    0.1490 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.5460    1.3750   -1.5540 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5580   -1.1710   -0.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6770   -2.0750   -0.3730 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5270   -2.4830    1.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750   -3.2800   -1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  9  1  0  0  0  0
  7  8  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  1  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 17 19  1  0  0  0  0
M  END
>  <ID>
tramadol

> <PRIMARY_SOM>
19 18

> <SECONDARY_SOM>
8

>  <Citation>
Subrahmanyam et al.,Drug Metab. Disp.,29,1146,2001

$$$$
trofosfamide
  MOE2008           3D

 17 17  0  0  1  0  0  0  0  0999 V2000
   -0.0370    1.4630    0.0150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500   -0.0020    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3740    1.8750    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6370    1.8390   -1.5110 P   0  0  3  0  0  0  0  0  0  0  0  0
   -0.4990   -0.4030    1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7870    2.2380    1.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0510    1.4100   -1.6060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5360    3.5010   -1.7630 N   0  0  3  0  0  0  0  0  0  0  0  0
    0.2320    1.0780   -2.6340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5160   -2.2010    1.6670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4700    2.8860    1.4470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.5230    4.1240   -0.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9960    3.7420   -3.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3030    1.4600   -3.9010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9810    5.4630   -0.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1200    2.9620   -4.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1920    6.2270    0.7280 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  7  2  0  0  0  0
  4  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  1  0  0  0  0
  8 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 16  1  0  0  0  0
 15 17  1  0  0  0  0
M  END
>  <ID>
trofosfamide

> <PRIMARY_SOM>
13

> <SECONDARY_SOM>
12

>  <Citation>
May-Manke et al.,Cancer Chemother. Pharmacol.,44,327,1999

$$$$
troglitazone
  MOE2008           3D

 31 34  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3770    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0970    2.1490    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    2.0410    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.7840    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1860   -0.7170   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1960    1.4460    0.5620 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.4270    1.3320    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2800    3.5470    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4540    0.1810   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4020   -0.0550   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550   -2.2240   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4400    2.3370    0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8750    1.0570    2.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7440    2.0630    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5650   -0.7590   -0.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2380    3.4620    1.3920 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3690    4.2130    1.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4680    5.3850    2.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4280    3.8060    0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6180    6.1460    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5770    4.5710    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6710    5.7420    1.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9250    6.5740    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9050    6.1150    2.2080 C   0  0  3  0  0  0  0  0  0  0  0  0
   10.2350    6.8460    2.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3740    6.6800    3.8740 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.5620    7.5900    3.1390 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9460    6.7510    1.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7890    7.7100    4.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0040    8.3660    5.2350 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  6 12  1  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 11  1  0  0  0  0
  8 15  1  0  0  0  0
 11 16  1  0  0  0  0
 13 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  2  0  0  0  0
 21 23  2  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
 25 27  1  0  0  0  0
 26 28  1  0  0  0  0
 26 29  2  0  0  0  0
 27 30  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  2  0  0  0  0
M  END
>  <ID>
troglitazone

> <PRIMARY_SOM>
16

>  <Citation>
Yamazaki et al., Drug Metab. Disp.,27,1260,1999

$$$$
valproic_acid
  MOE2008           3D

 10  9  0  0  0  0  0  0  0  0999 V2000
   -0.5060   -0.6040   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8340   -0.0150   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2450   -0.3530    1.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680   -1.8050    1.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7920   -2.8300    0.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1440   -2.4530    0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0930   -1.8780    1.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2720   -2.0240    3.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410   -2.5360    3.7290 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2910   -1.7850    3.8120 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  2  0  0  0  0
M  END
>  <ID>
valproic_acid

> <PRIMARY_SOM>
1 2 6 7

> <SECONDARY_SOM>
3 5

>  <Citation>
Kiang et al., Toxicological Sciences, 2006, 94, 261-271

>  <DOI>
10.1093/toxsci/kfl096

$$$$
zotepine
  MOE2008           3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.3360    1.9550   -0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4180    0.5680   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.8440   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350    2.5460   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9420   -0.3530   -0.6610 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7550   -0.1860   -0.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6110    2.8100   -0.9440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3280    3.8820    0.6920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    1.7860   -0.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    0.5030   -1.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    0.4160   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0330    1.8850   -1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    3.3140    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.5460   -0.4110 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -0.2880   -3.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7900    2.4390   -3.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350    4.2160    3.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0410    0.2780   -4.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2850    1.6450   -4.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    4.1450    2.9580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1410    2.8340    3.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230    5.1130    3.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 10 12  2  0  0  0  0
 10 15  1  0  0  0  0
 12 16  1  0  0  0  0
 13 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 17 20  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
zotepine

> <PRIMARY_SOM>
22 21

> <SECONDARY_SOM>
5

> <TERTIARY_SOM>
18

>  <Citation>
Shigura et al.,Xenobiotica,29,217,1999

>  <DOI>
10.1080/004982599238623

$$$$
